BEGIN:VCALENDAR VERSION:2.0 PRODID:-//UM//UM*Events//EN CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:America/Detroit TZURL:http://tzurl.org/zoneinfo/America/Detroit X-LIC-LOCATION:America/Detroit BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20070311T020000 RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20071104T020000 RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTAMP:20250417T102613 DTSTART;TZID=America/Detroit:20250429T160000 DTEND;TZID=America/Detroit:20250429T170000 SUMMARY:Lecture / Discussion:Mechanical Information Processing in Multicellular Tissue DESCRIPTION:Margaret Gardel\, Ph.D.\nHorace B. Horton Professor of Physics\, Molecular Genetics and Cell Biology and Molecular Engineering \nUniversity of Chicago UID:130338-21865770@events.umich.edu URL:https://events.umich.edu/event/130338 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Buhl Res Cen for Human Genetics CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250401T104522 DTSTART;TZID=America/Detroit:20250430T093000 DTEND;TZID=America/Detroit:20250430T103000 SUMMARY:Lecture / Discussion:Dedifferentiation of the Stem Cells:Cell-fate Ambiguity for Tissue Homeostasis DESCRIPTION:2025 CDB Seminar Series\n\nWe are pleased to announce that Mayu Oguro\, M.D.\, Ph.D.- Assistant Professor\, University of Connecticut\, School of Medicine\, will present her talk titled \"Dedifferentiation of the Stem Cells:Cell-fate Ambiguity for Tissue Homeostasis\,\" on Wednesday\, April 30\, 2025\, at 9:30 a.m. This will be live in BSRB - ABC Seminar Rooms and via Zoom Meeting link: https://umich.zoom.us/j/96884969689.\n\nHosted by: \nSwati Yadlapalli\, Ph.D. UID:134547-21874480@events.umich.edu URL:https://events.umich.edu/event/134547 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250206T112023 DTSTART;TZID=America/Detroit:20250513T090000 DTEND;TZID=America/Detroit:20250513T163000 SUMMARY:Lecture / Discussion:BME Symposium and Glenn V. Edmonson Lecture DESCRIPTION:The annual BME Symposium with Glenn V. Edmonson Lecture is coming soon! Details on submitting a poster proposal and registration will be coming soon. UID:132437-21870946@events.umich.edu URL:https://events.umich.edu/event/132437 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION: CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250129T091440 DTSTART;TZID=America/Detroit:20250513T160000 DTEND;TZID=America/Detroit:20250513T170000 SUMMARY:Lecture / Discussion:Healing skin without a scar DESCRIPTION:Assistant Professor\nDermatology\nUniversity of Pennsylvania UID:129634-21864248@events.umich.edu URL:https://events.umich.edu/event/129634 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Buhl Res Cen for Human Genetics - 5915 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250409T131531 DTSTART;TZID=America/Detroit:20250520T160000 DTEND;TZID=America/Detroit:20250520T170000 SUMMARY:Lecture / Discussion:Reprogramming Secrets of the Ocular Pigment Epithelium DESCRIPTION:Katia Del Rio-Tsonis\, Ph.D.\nProfessor\, Biology\nCo-Director\, Center for Visual Sciences\nMiami University UID:130339-21865771@events.umich.edu URL:https://events.umich.edu/event/130339 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Buhl Res Cen for Human Genetics - 5915 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250515T055331 DTSTART;TZID=America/Detroit:20250528T120000 DTEND;TZID=America/Detroit:20250528T180000 SUMMARY:Lecture / Discussion:CPOD 30th Anniversary Symposium DESCRIPTION:The Center for Cell Plasticity and Organ Design (CPOD) will celebrate our 30th Anniversary Symposium on May 28\, in the Biomedical Science Research Building Kahn Auditorium. The Symposium is a significant milestone in the Center's history that marks its dedication and contribution to the UM scientific community. The Symposium is an afternoon event that is filled with a series of in-person speakers with a focus on the Center's past\, present and future\, followed by a reception.\n\nOnline registration is now closed\, onsite walk-in registration begins at 12:00pm on May 28th. Contact us at CPOD-contact@umich.edu if you have any questions. UID:131430-21868462@events.umich.edu URL:https://events.umich.edu/event/131430 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Taubman Biomedical Science Research Building - Kahn Auditorium CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250423T140651 DTSTART;TZID=America/Detroit:20250529T090000 DTEND;TZID=America/Detroit:20250529T170000 SUMMARY:Conference / Symposium:Saltiel Life Sciences Symposium 2025 DESCRIPTION:The 2025 Saltiel Life Sciences Symposium will examine the next-generation genetic tools that are unlocking new discoveries and understandings of human health and disease\, from synthetic biology and protein engineering to epigenomics and genome editing.\n\nThe 2025 Saltiel Life Sciences Symposium will examine the next-generation genetic tools that are unlocking new discoveries and understandings of human health and disease\, from synthetic biology and protein engineering to epigenomics and genome editing.\n\nSchedule\n9:00 a.m. | Welcome\n\n9:10 a.m. | Mary Sue and Kenneth Coleman Life Sciences Lecture\nClifford P. Brangwynne\, Ph.D.\, Director of the Omenn-Darling Bioengineering Institute\, June K. Wu ’92 Professor in Engineering\, Professor of Chemical and Biological Engineering\, Princeton University\n\n9:55 a.m. | Research talk\nJames Nuñez\, Ph.D.\, Assistant Professor of Molecular and Cell Biology\, University of California\, Berkeley\n\n10:25 a.m. | Research talk\nLeonardo Morsut\, Ph.D.\, Assistant Professor of Stem Cell Biology and Regenerative Medicine\, University of Southern California\n\n10:50 a.m. | Morning break\n\n11:10 a.m. | Research talk\nOmar Abudayyeh\, Ph.D.\, Assistant Professor\, Harvard Medical School\; Investigator\, Brigham and Women's Hospital\n\n11:40 a.m. | Research talk\nDanwei Huangfu\, Ph.D.\, Member\, Developmental Biology Program\, Sloan Kettering Institute\; Professor\, Cell and Developmental Biology Program\, Weill Graduate School of Medical Sciences\, Cornell University\n\n12:10 p.m. | Research talk\nJustin Crocker\, Ph.D.\, Group Leader\, European Molecular Biology Laboratory\n\n12:35 p.m. | Poster session and lunch\n\n2:00 p.m. | Research talk \nMichael Lin\, M.D.\, Ph.D.\, Associate Professor of Neurobiology and Bioengineering\, Stanford University\n\n2:50 p.m. | Research talk \nLi Ye\, Ph.D.\, Abide-Vividion Chair in Chemistry and Chemical Biology and Professor of Neuroscience\, Scripps Research\; Howard Hughes Medical Institute Investigator\n\n3:15 p.m. | Afternoon break\n\n3:35 p.m. | Research talk\nJared Toettcher\, Ph.D.\, Deputy Director of the Omenn-Darling Bioengineering Institute\, Associate Professor of Molecular Biology and Bioengineering\, Princeton University\n\n4:05 p.m. | Research talk\nPulin Li\, Ph.D.\, Eugene Bell Career Development Professor of Tissue Engineering\, Massachusetts Institute of Technology\; Core Member\, Whitehead Institute\n\n4:35 p.m. | Research talk\nChangyang Linghu\, Ph.D.\, Assistant Professor of Cell and Developmental Biology and Assistant Professor of Biomedical Engineering\, University of Michigan\n\n5:00 p.m. | Closing remarks UID:135188-21876470@events.umich.edu URL:https://events.umich.edu/event/135188 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Palmer Commons - Forum Hall CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250512T090208 DTSTART;TZID=America/Detroit:20250723T100000 DTEND;TZID=America/Detroit:20250723T190000 SUMMARY:Workshop / Seminar:BME Summer Workshops @ Michigan DESCRIPTION:This two-day session will highlight novel physical devices for recording and manipulating neural activity\, AI/ML algorithms for brain decoding and control\, neuroprosthetic applications\, and where the field is heading in pioneering the future of brain innovation. This event is co-sponsored by BME\, Neurosurgery and the Neural Engineering Training Program. UID:135584-21876970@events.umich.edu URL:https://events.umich.edu/event/135584 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:North Campus Research Complex Building 18 - Dining Hall CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250512T093652 DTSTART;TZID=America/Detroit:20250724T090000 DTEND;TZID=America/Detroit:20250724T143000 SUMMARY:Workshop / Seminar:BME Summer Workshops @ Michigan DESCRIPTION:This two-day session will highlight novel physical devices for recording and manipulating neural activity\, AI/ML algorithms for brain decoding and control\, neuroprosthetic applications\, and where the field is heading in pioneering the future of brain innovation. This event is co-sponsored by BME\, Neurosurgery and the Neural Engineering Training Program. UID:135586-21876976@events.umich.edu URL:https://events.umich.edu/event/135586 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:North Campus Research Complex Building 18 - Dining Hall CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250814T151945 DTSTART;TZID=America/Detroit:20250828T153000 DTEND;TZID=America/Detroit:20250828T163000 SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series DESCRIPTION:Abstract:\nThe metabolic underpinnings of immune cells in various inflamed tissues\, such as the implant microenvironment or the diseased heart\, are poorly understood. For instance\, polylactide (PLA) is the most widely used biopolymer in medicine. Yet\, for decades\, PLA had been thought to activate immune cells by reducing surrounding pH because PLA biodegrades into monomers and oligomers of lactic acid. During my talk\, I will discuss an alternative paradigm underscoring immune cell metabolism (immunometabolism) as the pivotal determinant of the proinflammatory versus pro-regenerative tissue microenvironment with biodegradable and non-biodegradable biomaterial examples. Further related to tissue engineering\, I will present on reversing established cardiac dysfunction and fibrosis in heart failure (following myocardial infarction) via targeted and enzyme-responsive nanomaterials. Finally\, I will unveil my vision to revolutionize therapeutic strategies for the various phenotypes of heart failure by leveraging the metabolic underpinnings of immune and stromal cell populations\, thereby engineering next-generation clinical interventions that shape the future of medicine. UID:137586-21880415@events.umich.edu URL:https://events.umich.edu/event/137586 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250829T141535 DTSTART;TZID=America/Detroit:20250903T120000 DTEND;TZID=America/Detroit:20250903T140000 SUMMARY:Careers / Jobs:Ice Cream + Info on the Grove DESCRIPTION:Join MDP Staff and representatives from project sponsor JPMorgan Chase on the North Campus Grove for * free * ice cream and information about our upcoming recruitment for 2026 projects! UID:138240-21882662@events.umich.edu URL:https://events.umich.edu/event/138240 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:The Grove CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250829T151642 DTSTART;TZID=America/Detroit:20250904T153000 DTEND;TZID=America/Detroit:20250904T163000 SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series DESCRIPTION:Advancing Healthcare Through AI and Machine Learning Innovations\nAbstract:\nHealthcare constitutes nearly one-fifth of the U.S. economy and approximately 10% of the global economy\, yet it faces profound challenges\, including inequitable access\, an aging population\, and rising per capita costs. These factors underscore the urgent need for innovative solutions. In this talk\, we will present how artificial intelligence\, driven by the urgent needs of healthcare\, is advancing both clinical and technological frontiers. I will share our work on medical image reconstruction\, MRI-based automated diagnosis\, and AI-powered precision medicine solutions. These applications are built on specialized deep learning algorithms\, such as video-based AI and longitudinal imaging reasoning\, with a focus on integrating biological complexities into their design. By bridging engineering principles with clinical applications\, we aim to transform medical diagnostics and treatment while broadening AI's impact across disciplines\, paving the way for more effective and accessible healthcare solutions. UID:138534-21883180@events.umich.edu URL:https://events.umich.edu/event/138534 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250826T150015 DTSTART;TZID=America/Detroit:20250904T183000 DTEND;TZID=America/Detroit:20250904T193000 SUMMARY:Careers / Jobs:Texas Instruments - Corporate Information Session DESCRIPTION:Thursday\, September 4th\n9/4/2025 | 5:30 pm | EECS 1003 (food provided) \nMajors: Biomedical Engineering\, Chemical Engineering\, Computer Engineering\, Computer Science\, Data Science\, Electrical Engineering\, Industrial and Operations Engineering\, Materials Science and Engineering\, Mechanical Engineering\nPositions: Full-time\, Intern\nDegrees: Bachelors\, Masters\, PhD\nUS Citizenship or Permanent Resident\nResumes collected\n\nOur passion is to create a better world by making electronics more affordable through semiconductors.\n\nOur semiconductor chips can be found in every type of electronic system – from electric vehicles to industrial robots\, solar panels to satellites. \n\nWe were pioneers in the transition of the world from vacuum tubes to transistors and then to integrated circuits – and we’ve been advancing semiconductor technology for decades. Each generation of innovation builds upon the last to make technology smaller\, more efficient\, more reliable and more affordable – making it possible for semiconductors to go into electronics everywhere. We think of this as Engineering Progress. UID:138195-21882564@events.umich.edu URL:https://events.umich.edu/event/138195 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Electrical Engineering and Computer Science Building - 1003 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250827T155910 DTSTART;TZID=America/Detroit:20250907T103000 DTEND;TZID=America/Detroit:20250907T150000 SUMMARY:Careers / Jobs:F25 Professional Development (PD) Day DESCRIPTION:Sunday\, September 7th\, 2025 — 10:30 AM to 3:00 PM\nHH Dow Building\, Room 1013 (North Campus)\nRVSP REQUIRED: https://forms.gle/8owiUC2JnCs9f7cm6\n\nGet ready for the Career Fair with SWE! Participate in company-led seminars\, get personalized\nresume critiques\, and sharpen your skills in mock interviews with recruiters. Lunch is\nprovided\, and this event is open to ALL engineering students.\n\nQuestions? Email swe.car.pd@umich.edu! UID:138286-21882719@events.umich.edu URL:https://events.umich.edu/event/138286 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Herbert H. Dow Building - 1013 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250904T125900 DTSTART;TZID=America/Detroit:20250911T153000 DTEND;TZID=America/Detroit:20250911T163000 SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series DESCRIPTION:Abstract:\nNon-academic careers in technical consulting and project management. UID:138828-21883978@events.umich.edu URL:https://events.umich.edu/event/138828 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250807T181856 DTSTART;TZID=America/Detroit:20250912T150000 DTEND;TZID=America/Detroit:20250912T160000 SUMMARY:Workshop / Seminar:Grad School in the Biosciences Panel (PhD and MS) DESCRIPTION:Graduate students and postdocs from the MCDB department will discuss how to apply to graduate school and what to expect with graduate classes\, research\, and post-degree job searching. The panel will be open to both pre-submitted and live questions.\n\nRSVP: https://linktr.ee/FIRST_Org\n\nIn-Person Location: 1010 BSB\n\nPlease RSVP for hybrid Zoom info. UID:137225-21879984@events.umich.edu URL:https://events.umich.edu/event/137225 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Biological Sciences Building - 1010 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250910T134119 DTSTART;TZID=America/Detroit:20250918T153000 DTEND;TZID=America/Detroit:20250918T163000 SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series DESCRIPTION:Creating a Cellular “Google Map” of the Brain with Engineered Spatial Sequencing Technologies\nAbstract:\nCells are not independent\; they communicate and work synergistically in the brain. Unlike traditional approaches that rely on bulk assays\, novel spatial technologies preserve the tissue's architecture at near single-cell resolution\, allowing for more precise functional interpretation of the cell types and states. In this talk\, I will introduce spatial proteomics and spatial epigenetics\, two leading methods that enable in situ detection of proteins and open chromatin. Compared to spatial transcriptomics\, spatial proteomics directly addresses key challenges in visualizing cellular morphology and evaluating whether RNAs are the best proxies for proteins. I will discuss how these approaches advance our understanding of brain function and disease\, particularly in psychiatric disorders and traumatic brain injury. UID:139181-21885012@events.umich.edu URL:https://events.umich.edu/event/139181 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250922T105617 DTSTART;TZID=America/Detroit:20250924T150000 DTEND;TZID=America/Detroit:20250924T163000 SUMMARY:Lecture / Discussion:MICDE: Nobel Prize Lectures DESCRIPTION:The 2024 Nobel Prizes in Physics and Chemistry spotlight the reciprocal influence between artificial intelligence and the natural sciences. This MICDE special event examines the science and scientists recognized for foundational advances in neural networks that underpin modern machine learning (Physics)\, and for AI-enabled breakthroughs in protein structure prediction and computational protein design (Chemistry). The lectures will be followed by a moderated panel and an open\, cross-disciplinary discussion.\n\nSpeakers:\n- Charles Brooks\, Warner-Lambert/Parke-Davis Professor of Chemistry\, Cyrus Levinthal Distinguished University Professor of Chemistry and Biophysics\, will talk about the 2024 Nobel Prizes in Chemistry.\n\n- Veera Sundararaghavan\, Professor of Aerospace Engineering and the Director of Multiscale Structural Simulations Laboratory\, will talk about the 2024 Nobel Prizes in Physics.\n\n\nThe panel discussion\, followed by the lectures\, will address questions such as: What can AI do for science? How can it support existing ideas and create new ones? What can science do for AI?\n\nPanelists:\n- James Wells\, Professor of Physics\, University of Michigan\n\n- Indika Rajapakse\, Professor of Computational Medicine and Bioinformatics\, and Professor of Mathematics\, University of Michigan\n\n- Charles Brooks\, Warner-Lambert/Parke-Davis Professor of Chemistry\, Cyrus Levinthal Distinguished University Professor of Chemistry and Biophysics\n\n- Veera Sundararaghavan\, Professor of Aerospace Engineering and the Director of Multiscale Structural Simulations Laboratory\n\nModerator:\n- Karthik Duraisamy\, Professor of Aerospace Engineering\, Mechanical Engineering and Nuclear Engineering and Radiological Sciences and Samir and Puja Kaul Director of the Michigan Institute for Computational Discovery and Engineering UID:137247-21879987@events.umich.edu URL:https://events.umich.edu/event/137247 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Palmer Commons - Forum Hall CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250918T055136 DTSTART;TZID=America/Detroit:20250924T160000 DTEND;TZID=America/Detroit:20250924T170000 SUMMARY:Workshop / Seminar:CCMB/DCMB Seminar Series featuring Yang Xiao\, PhD (Prof. at UM) DESCRIPTION:Abstract\n\nCells are not independent\; they communicate and work synergistically in the brain. Unlike traditional approaches that rely on bulk assays\, novel spatial technologies preserve the tissue's architecture at near single-cell resolution\, allowing for more precise functional interpretation of the cell types and states. In this talk\, I will introduce spatial proteomics and spatial epigenetics\, two leading methods that enable in situ detection of proteins and open chromatin. Compared to spatial transcriptomics\, spatial proteomics directly addresses key challenges in visualizing cellular morphology and evaluating whether RNAs are the best proxies for proteins. I will discuss how these approaches advance our understanding of brain function and disease\, particularly in psychiatric disorders and traumatic brain injury.\n\nShort Bio\n\nYang Xiao is a molecular pathologist and bioengineer working to understand the cellular changes in cerebral microenvironments following traumatic brain injury. Dr. Xiao’s research integrates spatial transcriptomic\, epigenomic\, and proteomic data to build a cellular “Google Map” of the brain\, and to uncover the gene regulatory control mechanisms involved in injury remodeling and mood disorders.\n\nDr. Xiao completed her undergraduate studies in Molecular Biology at McGill University in Canada\, and conducted her Ph.D. in Biomedical Engineering at Yale University under the mentorship of Dr. Rong Fan. She carried out postdoctoral work in Systems Neuroscience and Gene Editing at Columbia University\, working with Dr. Kam Leong. UID:139505-21885649@events.umich.edu URL:https://events.umich.edu/event/139505 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Palmer Commons - Great Lakes North CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250910T135101 DTSTART;TZID=America/Detroit:20250925T153000 DTEND;TZID=America/Detroit:20250925T163000 SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series DESCRIPTION:Revolutionizing Immunotherapy: Bioengineered Immune Organs and Nanoscale Technologies\nAbstract:\nThe human immune system is a marvel of biological complexity\, yet its dysfunction underlies numerous diseases. Designing vaccines\, immunomodulatory drugs\, and cell therapies against infections\, cancer\, inflammatory conditions\, and age-related disorders requires a detailed understanding of how immune cells form and activate in primary\, secondary\, and ectopic tertiary immune organs. Traditionally\, research on the immune system has been restricted to in vivo approaches\, which do not allow for the detailed control of intracellular and extracellular processes\, and to 2D in vitro models\, which lack physiological relevance. These models are being investigated to understand immune function and dysfunction at the cellular\, tissue\, and organ levels. In this talk\, I will discuss my laboratory’s effort in developing synthetic\, human ex vivo immune organoids to replicate the structure and function of immune tissues. I will discuss strategies to combine engineered materials and immune cells from individuals to generate antibody-secreting cells in a dish or as organ-on-chip against viral and bacterial infections and describe immunogenicity testing efforts. I will further describe the use of human immune organoids in oncology and drug development space\, and subsequently describe the integration of immune organoids with complex mucosal organ-on-chip technologies\, with applications in inflammation\, infection\, and oncology. Complementing this\, I will introduce nanoengineered wires functionalized with cationic polymers to program naive T cells without pre-activation\, a critical advancement for adoptive T-cell therapies. By delivering single or multiple microRNAs\, I will describe how nanowires modulate T-cell fitness\, influencing proliferation\, phenotypic differentiation\, and effector molecule secretion. These programmed T cells exhibit enhanced in vivo protection against intracellular pathogens\, with tailored differentiation into T cell subtypes. UID:139185-21885014@events.umich.edu URL:https://events.umich.edu/event/139185 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250904T114244 DTSTART;TZID=America/Detroit:20250929T130000 DTEND;TZID=America/Detroit:20250929T140000 SUMMARY:Workshop / Seminar:2025/2026 Single Cell Spatial Analysis Program Monthly Seminar Series DESCRIPTION:In Person and via Zoom\nSCSAP Monthly Seminar Series- KICKOFF SEMINAR\nDate: Monday\, September 29th\, 2025\nTime: 1:00-2:00 PM EST\nLocation: NCRC Building 10 – Research Auditorium\nLunch Provided beginning at 12:30 in NCRC Building 10 Lobby\nSEMINAR WILL NOT BE RECORDED\n\nTITLE: Imaging the microbe-host interface with genome-scale microscopy\n\nFEATURING: \nJeffrey R. Moffitt\, Ph.D.\nAssistant Professor\, Department of Microbiology\, Harvard Medical School\nInvestigator\, Program in Cellular in Molecular Medicine\, Boston Children's Hospital\n\nFor more details Visit: https://singlecellspatialanalysis.umich.edu/monthlyseminarseries/\n \nZoom Meeting Link\n \nMeeting ID: 998 7259 4985\nPasscode: 786053 UID:138806-21883943@events.umich.edu URL:https://events.umich.edu/event/138806 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:North Campus Research Complex Building 10 - Research Auditorium CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250923T103903 DTSTART;TZID=America/Detroit:20251001T100000 DTEND;TZID=America/Detroit:20251001T110000 SUMMARY:Workshop / Seminar:Household Functioning and Its Impact Upon Low-Income Engineering Student Sense of Belonging DESCRIPTION:Abstract: The families and households from which engineering students come from\, such as those from low-income households\, play a central role in their success. However\, not all households function the same. Given the existent strains on families (e.g.\, inequity including racism and sexism)\, low-income students’ households provide students differential access to physical (e.g.\, computers)\, social (e.g.\, homework help)\, and emotional resources (e.g.\, support of mental health). For related reasons\, particularly that basic needs missingness creates more dire household situations\, low-income students are more likely to be impacted by adverse childhood experiences (ACEs). I claim that “household functioning\,” including ACEs\, can influence how low-income engineering students perceive themselves in relation to engineering\, such as through their sense of belonging. A sense of belonging is known to be central to engineering students’ success\, more so for low-income students in engineering. In this talk\, I will present my thoughts on household functioning and why I think it should be considered an important factor in our discussions of engineering students\, especially those from low-income backgrounds. In my discussion\, I provide insight into findings from my past and present work related to the topic. UID:139750-21886001@events.umich.edu URL:https://events.umich.edu/event/139750 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Ford Robotics Building - Room 2300 and Zoom CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250925T110628 DTSTART;TZID=America/Detroit:20251001T160000 DTEND;TZID=America/Detroit:20251001T170000 SUMMARY:Workshop / Seminar:CCMB/DCMB Weekly Seminar Series featuring James Zou\, PhD (Prof. at Stanford University) DESCRIPTION:Short Bio\n\nJames Zou\, PhD\, is an Associate Professor of Biomedical Data Science at Stanford University\, with courtesy appointments in Computer Science and Electrical Engineering. His work focuses on enhancing the reliability\, human compatibility\, and statistical rigor of AI\, with a particular interest in applications within human disease and health.\n\nDr. Zou earned his Ph.D. from Harvard in 2014. Prior to joining Stanford in 2016\, he was a member of Microsoft Research\, a Gates Scholar at Cambridge\, and a Simons Fellow at U.C. Berkeley. He is also a Chan-Zuckerberg Investigator and his lab is part of the Stanford AI Lab. His research has garnered significant support\, including two Chan-Zuckerberg Biohub Investigator Awards\, the Sloan Fellowship\, the NSF CAREER Award\, a Top Ten Clinical Achievement Award\, and faculty awards from Google\, Adobe\, and Amazon. UID:139872-21886259@events.umich.edu URL:https://events.umich.edu/event/139872 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Off Campus Location CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250917T131218 DTSTART;TZID=America/Detroit:20251002T153000 DTEND;TZID=America/Detroit:20251002T163000 SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series DESCRIPTION:Bridging Neural Circuits and Therapy: Advances in Deep Brain Stimulation\nAbstract:\nDeep brain stimulation (DBS) is an effective treatment for multiple neurological disorders\, including advanced Parkinson's disease (PD)\, through continuous high-frequency brain stimulation. While its clinical benefits are well documented\, the underlying mechanisms remain poorly understood. Due to the anatomical and cellular heterogeneity of brain tissue\, DBS can modulate diverse neuronal elements and circuits at and around the stimulation site\, many of which may not directly contribute to therapeutic effects. Moreover\, conventional DBS systems typically operate in open-loop mode\, delivering fixed stimulation parameters regardless of patient state or neural activity. Identifying the specific circuits that mediate therapeutic benefits is therefore critical for refining target selection and developing next-generation treatment strategies. Optogenetics provides a powerful tool to overcome the nonselective nature of DBS by enabling cell-type specific modulation of neural populations. By integrating optogenetic interventions with electrophysiological recordings\, computational modeling\, and behavioral assays in preclinical models of PD\, our work seeks to dissect the circuit-level mechanisms underlying DBS and systematically evaluate how modulation of defined neural pathways alleviates parkinsonian motor symptoms. In addition\, I will introduce our recent efforts toward the development and preclinical evaluation of closed-loop DBS systems\, which dynamically adjust stimulation in response to ongoing neural and behavioral states. Together\, these approaches aim to advance both our mechanistic understanding of DBS and the design of more effective\, adaptive neuromodulation therapies for PD. UID:139477-21885600@events.umich.edu URL:https://events.umich.edu/event/139477 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250902T211523 DTSTART;TZID=America/Detroit:20251007T160000 DTEND;TZID=America/Detroit:20251007T170000 SUMMARY:Lecture / Discussion:2025 CPOD Seminar Series: \"A primate genetic model organism\" DESCRIPTION:Mark Krasnow\, M.D.\, Ph.D.\nProfessor\nBiochemistry\nStanford University UID:138699-21883636@events.umich.edu URL:https://events.umich.edu/event/138699 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251001T112811 DTSTART;TZID=America/Detroit:20251008T090000 DTEND;TZID=America/Detroit:20251008T100000 SUMMARY:Workshop / Seminar:SCSAP Hosts: Stellaromics Inc. Tech Talk DESCRIPTION:IN-PERSON SEMINAR\n3D Spatial Multi-Omics for Neuroscience\, Oncology\, and More\nHOSTED BY SCSAP\nDATE: OCTOBER 8\, 2025\nTIME: 9:00 - 10:00 AM \nLOCATION: NCRC Building 10 –G00S030 South Atrium\n\nThis free tech talk will feature Stellaromics and their Pyxa platform\, the first 3D\, high-plex\, confocal spatial system!! Please come and hear more about how Pyxa can help advance your spatial research!!! Come and meet the team!\n\nFree seminar for everyone!\nFood and Refreshments will be served!! \n\nPlease register to ensure there is enough food for everyone UID:140131-21886661@events.umich.edu URL:https://events.umich.edu/event/140131 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:North Campus Research Complex Building 10 - South Atrium CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251003T142629 DTSTART;TZID=America/Detroit:20251009T120000 DTEND;TZID=America/Detroit:20251009T130000 SUMMARY:Lecture / Discussion:OHS Seminar Series - Membrane Dynamics and Mechanosensation: Intravital Imaging of Osteocyte Endocytosis DESCRIPTION:Title: Membrane Dynamics and Mechanosensation: Intravital Imaging of Osteocyte Endocytosis\nDate: 10/09/25\nTime: 12:00 PM - 1:00 PM \nLocation: School of Dentistry - G550 \nDescription: OHS Seminar Series\nPresenter: Dr. Karl Lewis\nHost: Dr. Lauren Surface\nSponsor: TEAM UID:140287-21886883@events.umich.edu URL:https://events.umich.edu/event/140287 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION: CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251002T082037 DTSTART;TZID=America/Detroit:20251009T153000 DTEND;TZID=America/Detroit:20251009T163000 SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series DESCRIPTION:Abstract:\nThe nascent field of microrobotics is experiencing a “Cambrian explosion” before our very eyes. Potential applications for these diminutive devices span an array of fields\, including healthcare\, exploration\, environmental monitoring\, search and rescue\, industrial maintenance\, and digital agriculture. However\, the design of microrobotics systems is inherently tied to scaling-law constraints\; as length scales decrease\, surface forces and viscous forces (among others) begin to dominate inertial forces. This leads to fabrication bottlenecks\, struggles with energy/power autonomy\, and the need for specialized and often unconventional actuators. \n\nIn this talk\, I will present three unconventional microactuators developed in my own group. Each leverages distinct physical principles to achieve high forces\, frequencies\, power densities\, and integration potential in microrobotic platforms. These innovations highlight both the limitations imposed by microscale regimes and the opportunities that emerge when we embrace nontraditional transduction mechanisms for locomotion and manipulation. UID:140186-21886714@events.umich.edu URL:https://events.umich.edu/event/140186 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250903T123136 DTSTART;TZID=America/Detroit:20251015T153000 DTEND;TZID=America/Detroit:20251015T170000 SUMMARY:Fair / Festival:COE Majors and Minors Fair DESCRIPTION:Undecided on an Engineering major? Considering a minor in Engineering or another UM school/college? Want to learn about co-curricular opportunities? Then this event is for you! \n\nJoin us at the COE Majors and Minors Fair on Wednesday\, October 15\, from 3:30 PM to 5:00 PM. Come speak with representatives from Engineering departments and programs as well as campus partners across campus. Free pizza will be provided for students who RSVP! UID:138724-21883764@events.umich.edu URL:https://events.umich.edu/event/138724 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Duderstadt Center CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251010T100714 DTSTART;TZID=America/Detroit:20251016T120000 DTEND;TZID=America/Detroit:20251016T130000 SUMMARY:Lecture / Discussion:OHS Seminar Series DESCRIPTION:Title: Towards Computational Reconstruction of Growth Plate Temporal Dynamics at Near-Cellular Resolution\nDate: 10/16/25\nTime: 12:00 PM - 1:00 PM \nLocation: G550 \nDescription: OHS Seminar Series\nPresenter: Dr. Justin Lian\nHost: Dr. Tomer Stern\nSponsor: OHS Seminar Series UID:140523-21887273@events.umich.edu URL:https://events.umich.edu/event/140523 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:1027 E. Huron Building - G550 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250929T130515 DTSTART;TZID=America/Detroit:20251016T120000 DTEND;TZID=America/Detroit:20251016T130000 SUMMARY:Workshop / Seminar:Tools and Technology Seminar Presented by Yang Xiao DESCRIPTION:Abstract\nThe human hippocampus plays a critical role in memory and emotion\, with dysfunction implicated in numerous neuropsychiatric disorders. However\, understanding its molecular pathology within the context of spatial architecture has remained challenging. This talk will introduce spatial proteomics as an emerging tool for dissecting complex cellular neighborhoods and their functions at single-cell resolution. It helped address two key problems in spatial transcriptomics: Can we detect cellular morphology? Are RNAs the best proxies for proteins? By utilizing 25-plex spatial proteomics through co-detection by indexing (CODEX)\, we established the experimental platform for profiling human hippocampus and developed a computational framework through the lens of cellular neighborhoods.\n\nAbout The Tools & Technology Seminar Series\n\nThe DCMB Tools and Technology Seminar Series is held in Palmer Commons\, Room 2036\, each Thursday at 12pm EST. Each seminar highlights a computational tool\, technology\, or methodology that is under development or in current use and is of special interest to DCMB and University researchers. Presenters are U-M researchers and students.\n\nThese seminars are live-streamed and recorded and made available for future viewing via the DCMB YouTube Channel UID:140030-21886501@events.umich.edu URL:https://events.umich.edu/event/140030 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Palmer Commons - 2036 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251003T074234 DTSTART;TZID=America/Detroit:20251016T153000 DTEND;TZID=America/Detroit:20251016T163000 SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series DESCRIPTION:Engineering Native Biological Complexity from the Inside–out and Outside–in\nAbstract:\nEngineering heterogenous multicellular tissue with native complexity remains one of the holy grails of regenerative medicine and basic biological research. As success in this regard would yield powerful bioengineered constructs useful in functional transplantation\, high-throughput drug screening\, and fundamental biology investigation\, research efforts in our lab have centered around developing and implementing tools to spatiotemporally customize living cell function both from the “outside–in” and from the “inside–out”. In this talk\, I will discuss some of our group’s recent successes in reversibly modifying the chemical and physical aspects of synthetic cell culture platforms with user-defined and grayscale control\, regulating cell-biomaterial interactions through user-programmable Boolean logic\, engineering microvascular networks that span nearly all size scales of native human vasculature (including capillaries)\, irreversibly photoassembling bioactive proteins within living cells\, and driving biomolecular condensate formation using de novo-designed proteins. Results will highlight our ability to modulate intricate cellular behavior including stem cell differentiation\, protein secretion\, and cell-cell interactions in 4D. UID:140254-21886827@events.umich.edu URL:https://events.umich.edu/event/140254 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251010T171612 DTSTART;TZID=America/Detroit:20251017T110000 DTEND;TZID=America/Detroit:20251017T120000 SUMMARY:Workshop / Seminar:Using Relational Data to Study Socio-academic Processes in Engineering Teaching and Learning DESCRIPTION:Engineering education researchers often assume that teaching and learning is relational and that students’ socioacademic relationships—with peers\, faculty\, and other institutional agents—can support or inhibit important processes and outcomes. However\, the dominant approach to studying socioacademic processes relies on the principles of methodological individualism\, where socioacademic issues are studied at the individual level using methods that assume observations are independent. In this talk\, we will describe two studies that use relational data\, where students (e.g.\, in classrooms\, in small teams) are modeled as social networks of agentic actors. In Study 1\, we use social network theory to model teamwork processes in small engineering teams. In study 2\, we use network analysis to study peer collaboration networks in a large\, introductory STEM class. The talk will include a discussion of methodological and ethical issues\, including challenges related to modeling sociodemographic characteristics\, missing data\, and social and emotional concerns\, in social networks studies. We will also discuss future directions for engineering education research. UID:140561-21887346@events.umich.edu URL:https://events.umich.edu/event/140561 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Duderstadt Center - Presentation Room 1180 and Zoom CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251014T112124 DTSTART;TZID=America/Detroit:20251020T180000 DTEND;TZID=America/Detroit:20251010T180000 SUMMARY:Presentation:Graduate Fellowships for Computational Science and Engineering DESCRIPTION:Join MICDE for an information session on graduate fellowships in computational science and engineering. Following an overview of existing opportunities\, a panel of recent fellowship recipients will answer questions. The event is primarily intended for juniors\, seniors\, and first-year graduate students\, but is open to all. \n\nRefreshments will be served\; a Zoom option is also available. UID:140562-21887350@events.umich.edu URL:https://events.umich.edu/event/140562 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:3150 Dow CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251007T092937 DTSTART;TZID=America/Detroit:20251022T160000 DTEND;TZID=America/Detroit:20251022T170000 SUMMARY:Workshop / Seminar:CCMB/DCMB Weekly Seminar Series featuring Hyunghoon Cho\, PhD (Prof. at Yale School of Medicine) DESCRIPTION:Abstract\n\nThe sensitive nature of genomic data poses significant challenges for data sharing and collaboration in biomedicine. Traditional safeguards\, such as access control mechanisms\, often lead to data fragmentation across silos\, hindering large-scale analysis. In this talk\, I will describe our recent work on secure federated (SF) algorithms\, which leverage cryptography and distributed computing to enable collaborative genomic research without compromising privacy. I will showcase practical tools we have developed for key analysis tasks\, including genome-wide association studies (Nature Genetics\, 2025)\, principal component analysis (IEEE S&P\, 2023)\, and the identification of genetic relatives (Genome Research\, 2024). Finally\, I will discuss our recent efforts to deploy these methods across the NIH All of Us and VA Million Veteran Program biobanks\, as well as the broader opportunities that privacy-enhancing technologies offer for advancing biomedical data science\n\nShort Bio\n\nHyunghoon (Hoon) Cho received his Ph.D. in Electrical Engineering and Computer Science at MIT in 2019. Previously\, he received his M.S. and B.S. with Honors in Computer Science from Stanford University. His research focuses on overcoming key computational challenges in analyzing massive and distributed biomedical data\, creating modern tools from applied cryptography and machine learning. He is especially interested in solving problems in the areas of biomedical data privacy\, single-cell genomics\, and network biology. He is a recipient of the NIH Director's Early Independence Award. UID:140009-21886498@events.umich.edu URL:https://events.umich.edu/event/140009 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Palmer Commons - Forum Hall CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251010T114222 DTSTART;TZID=America/Detroit:20251023T120000 DTEND;TZID=America/Detroit:20251023T130000 SUMMARY:Presentation:OHS Seminar Series - Epigenomics of Orofacial Clefts DESCRIPTION:Title: Epigenomics of Orofacial Clefts \nDate: 10/23/25 \nTime: 12:00 PM - 1:00 PM \nLocation: G550 \nDescription: OHS Seminar Series \nPresenter: Dr. Aline Petrin \nHost: Dr. Clarissa Souza Gomes da Fontoura \nSponsor: OHS UID:140533-21887292@events.umich.edu URL:https://events.umich.edu/event/140533 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION: CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251015T091740 DTSTART;TZID=America/Detroit:20251023T153000 DTEND;TZID=America/Detroit:20251023T163000 SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series DESCRIPTION:The clock is ticking – why it’s time to engineer biorhythms in vitro\nAbstract:\nThe mechanistic study of pathophysiology and therapeutic action has long relied upon the use of engineered in vitro cell culture systems. These systems\, however\, lack the periodic fluctuations\, or biorhythms\, in the cellular microenvironment that effectively integrate “time” into these culture platforms by providing physiological inputs necessary for cellular synchronization and circadian rhythms. Given the central role that circadian rhythms play in health and disease\, this absence is puzzling. For example\, cardiovascular disease\, diabetes\, osteoarthritis\, and asthma\, are just a few diseases with known circadian rhythm effects. Moreover\, more than half of the top 100 selling drugs target the product of a circadian gene\, and multiple clinical trials have retrospectively shown the impact of time-of-day dosing on improved outcomes and increased patient lifespan. The underlying reason conventional systems largely do not integrate temporal dynamics in vitro is because they either require the use of poorly scalable external flow control systems or manual fluid exchanges. In this talk\, I will discuss my group’s research focusing on the development of microfluidic technologies to address the challenges of embedding time within scalable in vitro systems using microfluidic circuits. Additionally\, I will describe microfluidic systems we have developed for the scalable production of microgels for use in packed bed reactors that allow us to perform rhythmic fluidic exchanges in 3D tissue cultures. UID:140721-21887529@events.umich.edu URL:https://events.umich.edu/event/140721 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250812T132507 DTSTART;TZID=America/Detroit:20251023T160000 DTEND;TZID=America/Detroit:20251023T200000 SUMMARY:Recreational / Games:MPowered Presents: Innovation Challenge DESCRIPTION:The MPowered Innovation Challenge\, sponsored by the Center for Entrepreneurship\, brings together brilliant minds from across U-M's diverse academic spectrum. This entrepreneurial game challenges participants to design\, build\, plan\, and execute\, utilizing teamwork and networking to win prizes.\n\nMeet MPowered members and learn about the University of Michigan's oldest and largest entrepreneurship student organization. Hear about the CFE's Entrepreneurial Practice Programs\, the Entrepreneurs Leadership Program and Perot Jain TechLab.\n\nDon't miss out on the fun! All majors and experience levels are welcome.\n\nRSVP Here: https://myumi.ch/P3dwg UID:137452-21880299@events.umich.edu URL:https://events.umich.edu/event/137452 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Duderstadt Center CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251017T144859 DTSTART;TZID=America/Detroit:20251023T190000 DTEND;TZID=America/Detroit:20251023T213000 SUMMARY:Film Screening:Cracking the Code: Phil Sharp and the Biotech Revolution DESCRIPTION:Thursday\, October 23 at 7:00 PM\nMichigan Theater - Screening Room\n603 E Liberty St\nAnn Arbor\, MI 48104. \n\nFilm | Documentary | NR | 1h 36m | 2025\n\nCracking the Code\, narrated by Mark Ruffalo\, is an inspiring story of vision\, perseverance\, and the power of science to change the world. Phil Sharp’s journey from a Kentucky farm boy to Nobel laureate embodies the American Dream and the triumph of entrepreneurial spirit. His 1977 groundbreaking discovery of RNA splicing rewrote the rules of molecular biology and ignited a life-saving scientific revolution\, laying the foundation for an industry that has become a cornerstone of global innovation and economic growth – and transformed the health of billions of patients worldwide.\n\nFeaturing a post-film Q&A with a panel presented by the University of Michigan Center for RNA Biomedicine and U-M Innovation Partnerships\n\nPanelists include:\n\nDr. Amanda Garner - Charles Walgreen Jr Professor\, Professor of Medicinal Chemistry and Director\, Interdepartmental Program in Medicinal Chemistry\, College of Pharmacy\n\nDr. Muneesh Tewari - Ray and Ruth Anderson-Laurence M Sprague Memorial Research Professor\, Professor of Internal Medicine\, Associate Division Chief\, Basic Research\, Medical School and Professor of Biomedical Engineering\, Medical School and College of Engineering\n\nDr. Nils Walter - Francis S Collins Collegiate Professor of Chemistry\, Biophysics and Biological Chemistry\, Professor of Chemistry\, Professor of Biophysics\, College of Literature\, Science\, and the Arts\, Program Associate\, Office of Graduate and Postdoctoral Studies and Professor of Biological Chemistry\, Medical School\n\nKate Remus\, Senior Associate Director & Business Development Group Lead\, University of Michigan Innovation Partnerships\n\nAdditional panelists TBD\n\nSpecial offer for current U-M students!\nUse the promo code UMRNA to unlock the Complimentary Ticket option. Good for one ticket\, while supplies last. Must show current U-M Student ID for entry. UID:139238-21885177@events.umich.edu URL:https://events.umich.edu/event/139238 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Off Campus Location - Michigan Theater Main Screening Room CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250929T141648 DTSTART;TZID=America/Detroit:20251030T120000 DTEND;TZID=America/Detroit:20251030T130000 SUMMARY:Workshop / Seminar:Tools and Technology Seminar by Ram Prakash DESCRIPTION:About the DCMB Tools & Technology Seminar Series\n\nThe DCMB Tools and Technology Seminar Series is held in Palmer Commons\, Room 2036\, each Thursday at 12pm EST. Each seminar highlights a computational tool\, technology\, or methodology that is under development or in current use and is of special interest to DCMB and University researchers. Presenters are U-M researchers and students.\n\nThese seminars are live-streamed and recorded and made available for future viewing via the DCMB YouTube Channel UID:140036-21886509@events.umich.edu URL:https://events.umich.edu/event/140036 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Palmer Commons - 2036 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251029T203606 DTSTART;TZID=America/Detroit:20251030T153000 DTEND;TZID=America/Detroit:20251030T163000 SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series DESCRIPTION:Intelligent and Accessible Sensing and Neurotechnology Platforms for Next-Generation Medicine\nAbstract:\nDespite major advances in consumer electronics such as smartphones\, modern healthcare systems still lag behind in accessibility\, sophistication\, and data integration. For much of the global population\, medical and their analytical tools remain far less advanced than the technologies used in daily life. To bridge this gap between everyday devices and medical innovation\, my research centers on three major themes: First\, I will present the development of a low-cost\, point-of-care automated diagnostic platform that enables multiplexed biochemical testing with an order-of-magnitude reduction in cost compared to currently available commercial platforms. Second\, I will discuss machine learning-enhanced biosensing for cancer diagnostics\, where our recent work demonstrates thousand-fold precision improvements through full-spectrum and multi-resonance modeling compared to conventional one-dimensional fittings. Finally\, I will introduce hybrid dynamic optogenetic–electrophysiology neural interfaces\, combining metasurface-based beam steering with minimally invasive carbon-fiber arrays for adaptive and chronic closed-loop neuromodulation. UID:140768-21887593@events.umich.edu URL:https://events.umich.edu/event/140768 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251030T074349 DTSTART;TZID=America/Detroit:20251107T150000 DTEND;TZID=America/Detroit:20251107T170000 SUMMARY:Lecture / Discussion:Alan J. Hunt Memorial Lecture-U-M Biomedical Engineering--NOTE LOCATION CHANGE to NCRC BUILDING 10 AUDITORIUM DESCRIPTION:2025 Alan J. Hunt Memorial Lecture\n\nMeasuring the Health of the Brain: From Global Networks to Local Biomarkers\nAbstract:\nHow do we measure the health of the brain? Unlike blood pressure or cholesterol\, there is no single number that captures brain function. We are developing the Brain Entropy Index (BEI)\, a new measure that integrates thermodynamics\, statistical modeling\, and brain imaging to provide a global indicator of brain health. Using data from modalities such as EEG\, fMRI\, and MEG\, the BEI can reliably separate healthy from diseased brains\, offering promise as a universal screening tool.\n\nYet\, just as a blood test might flag “illness” without specifying the disease\, a global index cannot by itself identify the underlying condition. Neurological disorders are defined by distinct local network dynamics\, and it is these dynamics that can give rise to robust biomarkers. One example is EpiScalp\, a computational tool we developed to model local brain networks from scalp EEG. EpiScalp can differentiate true epilepsy from seizure-mimicking disorders and from healthy brains\, providing a disorder-specific biomarker.\n\nTogether\, these approaches demonstrate a two-tiered framework: global measures can screen for health versus disease\, while local network dynamics serve as biomarkers that refine diagnosis and define specific conditions. More broadly\, this talk will illustrate how concepts from systems & control theory\, physics\, and data science can converge to open new frontiers in neuroscience and medicine.\n \nBio:\nSridevi Sarma received a B.S. in Electrical Engineering from Cornell University\, and an M.S. and Ph.D. in Electrical Engineering and Computer Science from Massachusetts Institute of Technology (MIT). She was a Postdoctoral Fellow in the Brain and Cognitive Sciences Department at the MIT. Dr. Sarma is now a Professor in the Institute for Computational Medicine\, Department of Biomedical Engineering\, at Johns Hopkins University. Her research includes modeling\, estimation and control of neural systems using electrical stimulation to better diagnose and treat neurological disorders. She is PI for NeuroTech Harbor\, an NIH-funded BluePrint Hub for NeuroTechnologies and recently won an NIH Research Investigator Award (R35) that supports her translational research in epilepsy for 8 years. She is a recipient of the the Burroughs Wellcome Fund Careers at the Scientific Interface Award\, the Krishna Kumar New Investigator Award from the North American Neuromodulation Society\, a recipient of the Presidential Early Career Award for Scientists and Engineers and the Whiting School of Engineering Robert B. Pond Excellence in Teaching Award. UID:140185-21886713@events.umich.edu URL:https://events.umich.edu/event/140185 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:North Campus Research Complex Building 10 - Auditorium CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251103T114457 DTSTART;TZID=America/Detroit:20251113T153000 DTEND;TZID=America/Detroit:20251113T163000 SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series DESCRIPTION:When the Air We Breathe Ages Our Arteries: Mechanisms of Vascular Injury from Fire Smoke Inhalation\nAbstract:\nCardiovascular aging reflects the gradual loss of vascular compliance and serves as a powerful indicator of overall cardiovascular health. Hallmarks of this process include inflammation\, oxidative stress\, endothelial dysfunction\, and aortic stiffening\, all of which compromise the ability of large arteries to regulate blood flow and pressure\, increasing susceptibility to disease. Our research program seeks to uncover the molecular mechanisms that drive these functional shifts and to determine how environmental stressors accelerate vascular aging. In this seminar\, I will first highlight recent findings from our work mapping the trajectory of aortic aging in mice. Using single-cell transcriptomics and mechanical testing\, we identified immune cell accumulation\, extracellular matrix remodeling\, and altered Piezo-1 signaling as key processes that increase aortic stiffness with age. I will then discuss how chronic exposure to wildfire smoke\, an increasingly common environmental hazard\, can recapitulate age-associated vascular maladaptation. Through a mouse model scaled to the exposure of wildland firefighters\, we demonstrated that repeated inhalation of Douglas Fir smoke induces inflammation\, oxidative and nitrosative stress\, endothelial dysfunction\, and fibrotic remodeling of the aortic wall\, leading to vascular stiffening and elevated blood pressure. Collectively\, these studies frame vascular aging as a unifying lens through which to understand the cardiovascular consequences of environmental exposures and highlight pathways that may guide future prevention and intervention strategies. UID:141406-21888772@events.umich.edu URL:https://events.umich.edu/event/141406 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251010T110229 DTSTART;TZID=America/Detroit:20251117T090000 DTEND;TZID=America/Detroit:20251117T173000 SUMMARY:Conference / Symposium:U-M Annual Data Science & AI Summit 2025 DESCRIPTION:The U-M Data Science and AI Summit is the largest annual data science and AI event on campus. This event brings together the U-M data science and AI research community and their external collaborators to build research vision and collaboration. It also showcases the breadth and depth of U-M data science and AI research\, from theory and methodology development to the transformative use of data and AI to address scientific and societal challenges in all domains. The event is free for all U-M faculty\, staff\, students and alumni. UID:139512-21885676@events.umich.edu URL:https://events.umich.edu/event/139512 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Michigan Union CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251010T110229 DTSTART;TZID=America/Detroit:20251118T090000 DTEND;TZID=America/Detroit:20251118T173000 SUMMARY:Conference / Symposium:U-M Annual Data Science & AI Summit 2025 DESCRIPTION:The U-M Data Science and AI Summit is the largest annual data science and AI event on campus. This event brings together the U-M data science and AI research community and their external collaborators to build research vision and collaboration. It also showcases the breadth and depth of U-M data science and AI research\, from theory and methodology development to the transformative use of data and AI to address scientific and societal challenges in all domains. The event is free for all U-M faculty\, staff\, students and alumni. UID:139512-21885677@events.umich.edu URL:https://events.umich.edu/event/139512 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Michigan Union CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250929T142746 DTSTART;TZID=America/Detroit:20251120T120000 DTEND;TZID=America/Detroit:20251120T130000 SUMMARY:Workshop / Seminar:Tools and Technology Seminar by Doug Craig DESCRIPTION:Abstract\n\nWhat happens when you bring a large language model to the front lines of care? This talk explores our work building a voice-driven\, edge-deployed LLM system for use in the emergency department. With no internet connection\, low-latency inference\, and a fully local privacy-preserving design\, our system runs entirely offline. It adapts dynamically to both the patient and the physician's specialty\, enabling tailored language understanding in fast-moving clinical contexts. We'll unpack key design choices\, challenges of real-time interaction\, and what it takes to make language models clinically useful when seconds matter.\n\nAbout The Tools & Technology Seminar Series\n\nThe DCMB Tools and Technology Seminar Series is held in Palmer Commons\, Room 2036\, each Thursday at 12pm EST. Each seminar highlights a computational tool\, technology\, or methodology that is under development or in current use and is of special interest to DCMB and University researchers. Presenters are U-M researchers and students.\n\nThese seminars are live-streamed and recorded and made available for future viewing via the DCMB YouTube Channel UID:140039-21886513@events.umich.edu URL:https://events.umich.edu/event/140039 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Palmer Commons - 2036 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251114T091653 DTSTART;TZID=America/Detroit:20251204T153000 DTEND;TZID=America/Detroit:20251204T163000 SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series DESCRIPTION:Developing a novel in-silico tool for heterochiral macrocycle design\nAbstract:\nAntibodies and small molecules have been powerful tools in targeting disease-related proteins. However\, there remain many challenging targets—such as flat or featureless intracellular surfaces—that are often inaccessible to these modalities. This is where peptides come in. Peptides are particularly exciting because they can be synthesized via solid-phase methods\, penetrate cells\, and bind to flat protein interfaces that are otherwise undruggable. Despite this promise\, designing effective peptides has remained a significant challenge. In our lab\, we’re developing new computational and experimental tools to overcome these limitations. Today\, I’ll be talking about CyclicCEA and CyclicMPNN\, two current methods for rapid generation of Gly or Ala cycles. If time permits\, I will also talk about their use as a binder design. UID:141865-21889545@events.umich.edu URL:https://events.umich.edu/event/141865 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20250902T211924 DTSTART;TZID=America/Detroit:20251209T160000 DTEND;TZID=America/Detroit:20251209T170000 SUMMARY:Lecture / Discussion:2025 CPOD Seminar Series: “Plasma lipids are regulators of energy expenditure” DESCRIPTION:Judith Simcox\, Ph.D.\nAssistant Professor\nBiochemistry\nUniversity of Wisconsin-Madison UID:138700-21883637@events.umich.edu URL:https://events.umich.edu/event/138700 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Buhl Res Cen for Human Genetics - 5915 Buhl CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260106T082528 DTSTART;TZID=America/Detroit:20260108T150000 DTEND;TZID=America/Detroit:20260108T160000 SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series DESCRIPTION:Global Women's Health Innovation\nAbstract:\nDhanu Thiyag\, MD MPH FACOG is an Assistant Professor of Obstetrics and Gynecology and Affiliate Faculty of Biomedical Engineering at the University of Michigan. As a clinician-scientist\, she focuses on designing and clinically evaluating medical devices and simulation-based educational programming specifically for the goal of women’s health equity. This is crucial as medical devices and programming not designed for the context of use are typically neither sustained nor disseminated. Examples of her work include devices for cervical cancer screening to diagnosing postpartum hemorrhage as well as simulation-based education to prevent cesarean deliveries to conducting less invasive gynecology surgery. She also focuses efforts on capacity building for women in engineering and clinical research with efforts in Ghana\, Rwanda\, and the USA. She has been recognized for her efforts with a University of Michigan Outstanding International Collaboration Award and as a STAT Wunderkind. She will be presenting on her utilization of a human-centered design process from the needs assessment to validation testing. She will be using one of her devices and one of her simulation projects as an example. UID:143252-21892552@events.umich.edu URL:https://events.umich.edu/event/143252 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251117T080145 DTSTART;TZID=America/Detroit:20260113T160000 DTEND;TZID=America/Detroit:20260113T170000 SUMMARY:Lecture / Discussion:CPOD Winter 2026 Seminar Series: \"Uncovering defect mechanisms and apical polarity cues in neural tube organoids\" DESCRIPTION:Andrew Tidball\, Ph.D.\nResearch Assistant Professor\nNeurology\nUniversity of Michigan UID:141937-21889654@events.umich.edu URL:https://events.umich.edu/event/141937 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260109T103909 DTSTART;TZID=America/Detroit:20260115T150000 DTEND;TZID=America/Detroit:20260115T160000 SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series DESCRIPTION:Implementing EEG-Based Brain-Computer Interface Access to Commercial Speech Generating Devices\nAbstract:\nBrain-computer interfaces (BCIs) have long been considered a promising option for people with complex communication needs. However\, most BCIs remain in the laboratory and the few BCIs on the market are not integrated into the clinically useful augmentative and alternative communication (AAC) devices available from long-established companies. With small business funding from the National Institute on Deafness and Other Communication Disorders\, Dr. Jane Huggins from the University of Michigan and Dr. Katya Hill from Gannon University have been working closely with an AAC device manufacturer to create wearable BCI access to an existing product line of speech generating devices. These efforts have produced a BCI add-on accessory that can access the language features of the speech generating devices. Laboratory and in-home testing focused on realistic communication tasks shows the effectiveness of the BCI for real-world communication and challenges and areas for future improvements. \nBio:\nDr. Huggins has been active in brain-computer interface (BCI) research since 1994. Her dissertation research on electrocorticogram (ECoG) for BCI access to assistive technology resulted in the founding of the University of Michigan Direct Brain Interface Laboratory\, which she has led since 2007. Dr. Huggins trained in computer engineering and biomedical engineering at Carnegie Mellon University and the University of Michigan. She also completed a clinical rehabilitation engineering internship at the University of Michigan\, giving her a unique combination of skills for the development of BCI access to assistive technology and augmentative and alternative communication. Her current focus is on making electroencephalogram (EEG)-based BCIs interfaces practical for people who need them. Ongoing research directions include interfacing BCIs to commercially available assistive technologies\, improving BCI response time and no-control performance\, identifying features and support necessary for successful independent BCI use by people with physical impairments\, identifying the design preferences and priorities of potential BCI users\, BCI applications in cognitive testing\, and the identification and accommodation of user-specific characteristics that affect BCI function. She is particularly interested in the often ignored topic of how BCIs can remain available for communication but unobtrusive during periods when the user is not actively trying to make selections. Dr. Huggins was a founding member of the board of directors of the Brain-Computer Interface Society and now serves on the BCI Society's Communications Committee. Outside the lab\, Dr. Huggins enjoys knitting\, genealogy\, birdwatching\, cooking for her husband\, and being Mom to her college-age children. UID:143584-21893424@events.umich.edu URL:https://events.umich.edu/event/143584 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251210T113622 DTSTART;TZID=America/Detroit:20260118T230000 DTEND;TZID=America/Detroit:20260118T235900 SUMMARY:Meeting:APPLICATION DEADLINE EXTENDED TO JANUARY 18TH: Up to $30\,000 Grant For Student Sustainability Projects DESCRIPTION:The Student Sustainability Coalition is awarding up to $30\,000 for student driven projects that enhance sustainability or in some instances social sustainability for the University of Michigan's campus community. Attend grant office hours\, email\, or check out our webpage to learn more!\n\nLINK TO APPLY: https://forms.gle/k7ChrFbqbjkAnNjt8 UID:117733-21891124@events.umich.edu URL:https://events.umich.edu/event/117733 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:1027 E. Huron Building CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251113T152512 DTSTART;TZID=America/Detroit:20260120T160000 DTEND;TZID=America/Detroit:20260120T170000 SUMMARY:Lecture / Discussion:CPOD Winter 2026 Seminar Series: “Circadian regulation of metabolism shapes adipose remodeling” DESCRIPTION:Chelsea Hepler\, Ph.D.\nAssistant Professor\nMolecular & Integrative Physiology\nUniversity of Michigan UID:141854-21889531@events.umich.edu URL:https://events.umich.edu/event/141854 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260112T112056 DTSTART;TZID=America/Detroit:20260122T150000 DTEND;TZID=America/Detroit:20260122T160000 SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series DESCRIPTION:Non-invasive Histotripsy Cancer Treatment: The Road from Bench to Bedside\nAbstract:\nHistotripsy is the first non-invasive\, non-ionizing\, and non-thermal ablation technology that is based on ultrasound and invented by Dr. Xu and her colleagues at the University of Michigan. Imagine ultrasound delivered from outside the body is used to generate bubbles and destroy the target tumor\, without incision or injury. Pre-clinical studies have shown that ultrasound image-guided histotripsy can non-invasively and mechanically disrupt the target tumor into acellular debris while preserving large normal vessels\, nerves\, and bile ducts. Histotripsy tumor acellular debris is absorbed by the body\, resulting in tumor regression and increased survival benefit. Histotripsy induces significant innate and adaptive immune response and abscopal effect (shrinkage of off-target tumors) in murine tumor models. Multi-center clinical trials confirm that histotripsy produces tumor regression and provides evidence of abscopal effect in patients with primary and metastatic liver tumors. In October 2023\, the Edison histotripsy platform (HistoSonics) was approved by FDA for non-invasive treatment of liver tumors. The Edison system is based on the technology licensed from Dr. Xu’s lab and manufactured by HistoSonics\, a company co-founded by Dr. Xu. To Date\, histotripsy has been used to treat 3000 patients with liver tumors in 70+ hospitals. There are ongoing clinical trials in the U.S. and Europe on histotripsy treatment of renal tumors and pancreatic tumors. Dr. Xu will talk about the mechanism and instrumentation of histotripsy\, the latest pre-clinical and clinical progress\, and her journal to bring this technology from bench to bedside. \nBio:\nDr. Zhen Xu is the Li Ka Shing Endowed Professor of Biomedical Engineering\, and Professor of Radiology and Neurosurgery at the University of Michigan\, Ann Arbor\, MI. Her research focuses on ultrasound therapy and imaging. She is a pioneer and world leader of histotripsy. She has developed histotripsy for cancer\, neurological\, and cardiovascular applications. Her work has led to the FDA approval of histotripsy treatment of liver tumors. She has been elected as Fellow of National Academy of Inventors (NAI)\, American Institute of Medicine and Bioengineering (AIMBE)\, and IEEE. She received the IEEE Ultrasonics\, Ferroelectrics\, and Frequency Control (UFFC) Outstanding Paper Award in 2006\, Frederic Lizzi Award from the International Society of Therapeutic Ultrasound (ISTU) in 2015\, Lockhart Memorial Prize for Cancer Research in 2020\, and IEEE Carl Hellmuth Hertz Ultrasonics Award in 2024. She has published 140 peer-reviewed journal papers and has been awarded $50+ millions of external grant funding. She has 36 issued US and international patents. She is a principal investigator of grants funded by NIH\, Office of Navy Research\, American Cancer Association\, and Focused Ultrasound Foundation. She is the co-founder of HistoSonics. HistoSonics is valued at $3 billions through a recent private acquisition. UID:143705-21893683@events.umich.edu URL:https://events.umich.edu/event/143705 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251118T133619 DTSTART;TZID=America/Detroit:20260127T160000 DTEND;TZID=America/Detroit:20260127T170000 SUMMARY:Lecture / Discussion:CPOD Winter 2026 Seminar Series: “Visualizing gene regulation post traumatic brain injury with spatial epigenetics” DESCRIPTION:Yang Xiao\, Ph.D.\nAssistant Professor\nPathology\nUniversity of Michigan UID:141985-21889737@events.umich.edu URL:https://events.umich.edu/event/141985 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251224T134757 DTSTART;TZID=America/Detroit:20260128T173000 DTEND;TZID=America/Detroit:20260128T183000 SUMMARY:Careers / Jobs:Texas Instruments Corporate Information Session DESCRIPTION:1/28/2026 | 5:30 pm | DOW 2150 (FOOD PROVIDED: Cottage Inn Pizza)\nMajors: Biomedical Engineering\, Chemical Engineering\, Computer Engineering\, Computer Science\, Data Science\, Electrical Engineering\, Industrial and Operations Engineering\, Materials Science and Engineering\, Mechanical Engineering\nPositions: Full Time\, Intern\nDegrees: Bachelors\, Masters\, PhD\nResumes Collected\nUS Citizenship Required\n\nTexas Instruments designs\, manufactures\, tests\, and sells analog and embedded semiconductors in markets that include industrial\, automotive\, personal electronics\, communications equipment\, and enterprise systems. UID:143110-21892158@events.umich.edu URL:https://events.umich.edu/event/143110 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Herbert H. Dow Building - 2150 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260106T152104 DTSTART;TZID=America/Detroit:20260129T150000 DTEND;TZID=America/Detroit:20260129T160000 SUMMARY:Workshop / Seminar:Biomedical Engineering Seminar Series DESCRIPTION:Learning What Matters: Neural Mechanisms of Flexible Navigation\nAbstract:\nGoal-directed navigation in a dynamic world requires quickly identifying important locations and adapting behavioral plans to new information. In this talk I will describe neural circuit mechanisms of rapid spatial learning and of adapting to new information to guide navigation. Identifying crucial locations in a new environment depends on neural computations that rapidly represent locations and connect location information to key outcomes like food\, however the mechanisms to trigger these computations at behaviorally relevant locations is not well understood. We find that inhibitory interneurons in hippocampal CA3 play a causal role in identifying and exploiting new food locations. Inhibitory interneurons in CA3 drastically reduce firing on approach to and in goal locations. Sparse optogenetic stimulation to prevent goal-related decreases in interneuron firing impaired learning of goal locations and disrupted neural representations of goal locations. These results reveal that goal-selective decreases in inhibitory activity enable learning important locations. Navigation also requires rapidly updating choices in the face of new information. In hippocampus and prefrontal cortex\, neural activity representing future goals is theorized to support navigation planning. Yet how prospective goal representations incorporate new\, pivotal information is unknown. Using virtual reality\, we precisely introduced new crucial information during navigation and recorded neural activity as mice flexibly adapted their planned destinations. We found that new information triggered increased prospective representations and reorganization to rapidly shift to the new choice. This prospective code updating depended on the degree of behavioral adaptation needed. These studies reveal new mechanisms by which animals rapidly learn crucial new locations and adapt to new information that requires updating navigation plans.\n\nBio:\nDr. Annabelle Singer is the McCamish Foundation Early Career Professor in the Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. Her research seeks to understand how neural activity produces memories and regulates brain immune function\, with the goal of developing new therapies for brain disease. Dr. Singer’s work has shown that coordinated electrical activity across hippocampal neurons encodes memories and fails in models of Alzheimer’s disease. She discovered that driving specific patterns of neural activity\, such as gamma oscillations\, reduces Alzheimer’s pathology and alters brain immune function. Using non-invasive sensory stimulation\, she is translating these discoveries from rodents to humans to pioneer radically new treatments for disease.\n\nDr. Singer is a Packard Fellow\, Kavli Fellow\, and recipient of the National Academy of Engineering’s Gilbreth Lectureship\, the Society for Neuroscience’s Janett Rosenberg Trubatch Career Development Award\, and the American Neurological Association’s Derek Denny-Brown Young Neurological Scholar Award. Her discoveries have inspired more than 20 clinical trials of brain stimulation across multiple diseases and have been featured on PBS\, Nature News\, Quanta Magazine\, The New York Times\, Radiolab\, and multiple documentaries. Dr. Singer trained as a postdoctoral fellow in Ed Boyden’s Synthetic Neurobiology Group at MIT and earned her Ph.D. in Neuroscience at UCSF. UID:143328-21892907@events.umich.edu URL:https://events.umich.edu/event/143328 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251114T080201 DTSTART;TZID=America/Detroit:20260203T160000 DTEND;TZID=America/Detroit:20260203T170000 SUMMARY:Lecture / Discussion:CPOD Winter 2026 Seminar Series: \"Engineering regenerative microenvironments: Guiding cell plasticity through niche design and nanoscale mediators\" DESCRIPTION:Jae-Won Shin\, Ph.D.\nAssociate Professor\nDentistry-Biologic & Materials Science\nUniversity of Michigan UID:141861-21889542@events.umich.edu URL:https://events.umich.edu/event/141861 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260127T070323 DTSTART;TZID=America/Detroit:20260205T150000 DTEND;TZID=America/Detroit:20260205T160000 SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series DESCRIPTION:Brain tumors are organized as active nematic liquid crystals\n\nAbstract:\nWhether gliomas consist of random accumulations of cells or are self-organizing remains unknown. If large scale order exists\, it should manifest as invariant structures across different tumors. Recently\, we described the existence of oncostreams\, fascicles of elongated mesenchymal-like cells that are found in gliomas in both rodent and human tumors. In this presentation\, I will discuss that glioma brain tumors in vivo\, and in vitro\, are structured as active nematic liquid crystals. Building on our previous work that gliomas exhibit self-organized\, aligned\, multicellular structures\, termed oncostreams\, I will show that gliomas display nematic order\, topological defects\, disclinations\, and quasi-long range order in 2D and in 3D. Significantly\, the amount of nematic order scales with tumor aggression - suggesting crystalline order contributes to tumor malignancy - constituting a novel potential therapeutic target for this incurable cancer. Potential novel therapeutic approaches based on this new understanding of the structure of gliomas will be discussed. \n\nBio:\nDr. Lowenstein graduated MD\, Ph.D. from the University of Buenos Aires\, Argentina. Following postdoctoral work at The Johns Hopkins University\, NIH\, and Oxford University he opened his first lab at the University of Dundee\, Scotland. Subsequently\, he has taught and researched at the University of Wales\, Cardiff\, the University of Manchester\, UK\, and UCLA and Cedars-Sinai Medical Center\, in Los Angeles\, CA. He has been at the University of Michigan since 2011. His interests lie in understanding and curing brain tumors. Most recently\, he has been exploring the physical organization of brain tumors\, as will be discussed during his presentation. UID:144608-21895563@events.umich.edu URL:https://events.umich.edu/event/144608 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251114T080452 DTSTART;TZID=America/Detroit:20260210T160000 DTEND;TZID=America/Detroit:20260210T170000 SUMMARY:Lecture / Discussion:CPOD Winter 2026 Seminar Series: \"When red cells talk to bone ‒ Crosstalk mechanisms in musculoskeletal disorders\" DESCRIPTION:Annemarie Lang\, D.V.M.\, Ph.D.\nAssistant Professor\nOrthopaedic Surgery\nUniversity of Michigan UID:141862-21889543@events.umich.edu URL:https://events.umich.edu/event/141862 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260204T104352 DTSTART;TZID=America/Detroit:20260212T150000 DTEND;TZID=America/Detroit:20260212T160000 SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series DESCRIPTION:From Concept to Care: Leading R&D and Operations in the Medical Device Industry\nAbstract:\nThis seminar focuses on the career journey and real-world experiences of a Vice President of R&D and Operations Engineering in the medical device industry. Students will gain insight into how careers evolve across engineering\, innovation\, operations\, and leadership\, and what skills\, mindsets\, and decisions enable long-term success. The session offers practical guidance on navigating industry roles\, learning from early career choices\, and building a path at the intersection of engineering\, healthcare\, and business impact.\n\nBio:\nWith more than 25 years in the medical device industry\, Carlos M. Ortega (Vice President of R&D and Operations Engineering) has built a career at the intersection of innovation\, engineering execution\, and clinical impact. Having held leadership and functional roles at companies such as Terumo\, Medtronic\, and Johnson & Johnson\, he has contributed to the development and commercialization of technologies across cardiovascular\, neurovascular\, aortic\, and peripheral vascular therapies.\n\nHis experience spans predominantly R&D leadership\, complemented by roles in operations engineering and product marketing\, giving him a unique perspective on how ideas translate into manufacturable\, clinically meaningful products. Throughout his career\, he has led multidisciplinary teams\, navigated complex regulatory environments\, and helped organizations align technology development with patient and business needs.\n\nHe is passionate about the impact medical devices have on the lives or the patients they serve and in mentoring the next generation of professionals by sharing practical insights into building impactful careers in the medical device industry. UID:145043-21896577@events.umich.edu URL:https://events.umich.edu/event/145043 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260202T132529 DTSTART;TZID=America/Detroit:20260217T100000 DTEND;TZID=America/Detroit:20260217T110000 SUMMARY:Livestream / Virtual:Careers in the Biosciences (Virtual Panel) DESCRIPTION:University of Michigan staff discuss their career paths\, including graduate/medical training\, academic/industry research\, consulting\, and teaching.\n\nVirtual panel - RSVP for link: https://linktr.ee/FIRST_Org\n\nPanelists:\nDr. Zie Craig\, PhD\nDr. Emma Thornton-Kolbe\, PhD\nDr. Chris Ting\, MD UID:144925-21896158@events.umich.edu URL:https://events.umich.edu/event/144925 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Off Campus Location CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260106T103655 DTSTART;TZID=America/Detroit:20260219T120000 DTEND;TZID=America/Detroit:20260219T130000 SUMMARY:Workshop / Seminar:DCMB Tools and Technology Seminar by Mukai Wang DESCRIPTION:Abstract\nMicrobiome differential abundance analysis remains a challenging problem despite multiple methods proposed in the literature. The excessive zeros and compositionality of metagenomics data are two main challenges for differential abundance analysis. We propose a novel method called “analysis of differential abundance by pooling Tobit models” (ADAPT) to overcome these two challenges. ADAPT uniquely treats zero counts as left-censored observations to facilitate computation and enhance interpretation. ADAPT also encompasses a theoretically justified way of selecting non-differentially abundant microbiome taxa as a reference for hypothesis testing. We generate synthetic data using independent simulation frameworks to show that ADAPT has more consistent false discovery rate control and higher statistical power than competitors. We use ADAPT to analyze 16S rRNA sequencing of saliva samples and shotgun metagenomics sequencing of plaque samples collected from infants in the COHRA2 study. The results provide novel insights into the association between the oral microbiome and early childhood dental caries.\n\nAbout the DCMB Tools & Technology Seminar Series\n\nThe DCMB Tools and Technology Seminar Series is held in Medical Science Building 1 (MS1)\, Room 4B700\, each Thursday at 12pm EST. Each seminar highlights a computational tool\, technology\, or methodology that is under development or in current use and is of special interest to DCMB and University researchers. Presenters are U-M researchers and students.\n\nThese seminars are live-streamed and recorded and made available for future viewing via the DCMB YouTube ChannelAbout the DCMB Tools & Technology Seminar Series\n\nThe DCMB Tools and Technology Seminar Series is held in Medical Science Building 1 (MS1)\, Room 4B700\, each Thursday at 12pm EST. Each seminar highlights a computational tool\, technology\, or methodology that is under development or in current use and is of special interest to DCMB and University researchers. Presenters are U-M researchers and students.\n\nThese seminars are live-streamed and recorded and made available for future viewing via the DCMB YouTube Channel UID:143260-21892595@events.umich.edu URL:https://events.umich.edu/event/143260 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Medical Science Unit I - Room 4B700 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260210T142826 DTSTART;TZID=America/Detroit:20260219T150000 DTEND;TZID=America/Detroit:20260219T160000 SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series DESCRIPTION:Advancing Ultrasound Therapy and Imaging: Towards High-Precision\, Real-time Solutions\n\nAbstract:\nAchieving high-precision diagnosis and therapy with ultrasound is challenging due to the heterogeneous nature of biological tissues. This seminar will present recent technological advances in ultrasound to improve both imaging performance and therapeutic capability.\n\nThe first part of the seminar will introduce transcranial histotripsy as a non-invasive brain therapy. Histotripsy is a non-thermal\, non-ionizing ultrasound therapy that mechanically fractionates target tissue through acoustic cavitation generated by short\, high-intensity ultrasound pulses. Transcranial histotripsy is particularly challenging because the intact human skull introduces severe attenuation and phase aberration. This seminar will discuss the specialized instrumentation for transcranial histotripsy\, methods to ensure precise targeting and real-time monitoring (including skull aberration correction and cavitation imaging)\, and feasibility and safety evaluation of transcranial histotripsy in preclinical studies.\n\nThe second half of the seminar will focus on ultrafast ultrasound imaging using large-aperture arrays. By combining ultrafast acquisition techniques with parallel computing\, this approach enables high-resolution volumetric imaging over a large field of view at video-rate frame rates. Two clinically relevant applications will be presented: panoramic spine imaging for diagnosis and interventional guidance\, and breast ultrasound tomography for early cancer screening. Finally\, we will discuss remaining technical challenges for clinical translation and highlight how advances in ultrafast imaging can be integrated with histotripsy to enable safer\, more precise therapies.\n\nBio:\nDr. Ning Lu is a Senior Ultrasound Engineer at United Imaging Healthcare North America in Bellevue\, Washington. She completed her postdoctoral training in the Department of Radiology at Stanford University under the mentorship of Prof. Katherine W. Ferrara\, where she developed high-resolution 3D ultrasound imaging techniques for diagnostic and interventional guidance. Dr. Lu received her Ph.D. in Biomedical Engineering and Scientific Computing (joint degree) from the University of Michigan in 2023\, working with Prof. Zhen Xu on MR-guided transcranial histotripsy for non-invasive brain therapy. Her research interests include biomedical ultrasound\, medical instrumentation\, parallel computing\, and AI-driven imaging science. Her long-term career goal is to develop high-precision\, affordable\, personalized ultrasound solutions for therapy\, diagnosis\, and health monitoring. UID:145330-21897104@events.umich.edu URL:https://events.umich.edu/event/145330 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20251114T080730 DTSTART;TZID=America/Detroit:20260224T160000 DTEND;TZID=America/Detroit:20260224T170000 SUMMARY:Lecture / Discussion:CPOD Winter 2026 Seminar Series: \"How cells force the gut into shape\" DESCRIPTION:Tyler Huycke\, Ph.D.\nAssistant Professor\nMolecular\, Cellular\, & Developmental Biology\nUniversity of Michigan UID:141863-21889544@events.umich.edu URL:https://events.umich.edu/event/141863 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260129T164237 DTSTART;TZID=America/Detroit:20260225T120000 DTEND;TZID=America/Detroit:20260225T133000 SUMMARY:Livestream / Virtual:Building Industry Partnerships Webinar Series DESCRIPTION:Federal funding trends\, including from NSF\, DOE and ARPA agencies\, indicate increasing interest in translational research – supporting the pathways for fundamental discoveries to have broader societal\, economic or public impact. New funding programs might require researchers to demonstrate their research impact at the proposal stage through established partnerships with companies that signal market interest or investment\, formal commitments like licensing agreements\, and/or evidence of technology readiness levels. Researchers who build these industry partnerships in advance will have a critical edge in a competitive funding landscape.\n\nThe Office of Research Development will host a webinar series for U-M researchers that explains why and how to build industry partnerships that advance mutual R&D goals. Webinars will take place noon-1:30 pm each day\; calendar invites will be sent upon registration. \n\nFebruary 25: Discovery to Innovation - Gain a practical framework for deciding when to engage industry\, how to demonstrate impact credibly and which funding mechanisms align with research maturing and scholarly goals.\nMarch 26: Industry Engagement for Faculty: From Early Signals to Funded Partnerships - Learn meaningful engagement strategies across the research lifecycle\, emphasizing alignment with academic incentives\, research integrity and appropriate funding mechanisms. \nApril 9: Building Industry Partnerships that Last: Whom to Talk to\, What to Ask - Learn how to identify the right industry counterparts\, structure early conversations to surface meaningful research and translational opportunities and set expectations that can evolve into sustained collaboration. \nContact RD-Support@umich.edu with questions. UID:144802-21895959@events.umich.edu URL:https://events.umich.edu/event/144802 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Off Campus Location CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260211T085633 DTSTART;TZID=America/Detroit:20260226T150000 DTEND;TZID=America/Detroit:20260226T160000 SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series DESCRIPTION:Cellular Mechanisms of Vascular Calcification and Opportunities for Targeted Therapies\n\nAbstract:\nVascular calcification is the major precursor to cardiovascular disease and is further exacerbated by chronic kidney disease. Phosphate is a known precursor to vascular calcification which leads to the onset of CVCs and other complications. Increased serum levels of inorganic phosphate lead to calcification of vascular smooth muscle cells and a phenotypic switch to an osteoblast-like cell. Once thought to be a passive process of calcium and phosphate deposition within arteries\, vascular calcification is now known to be an active\, cell-regulated condition. There is a clinical need to develop a therapy for vascular calcification that reduces calcification without causing arterial damage similar to current therapies such as endovascular stent and atherectomy. We are examining the role of phosphate in vascular smooth muscle cell calcification and the potential of protein therapy to reduce calcification.\n\nBio: \nDr. C. LaShan Simpson Hendrix is an Associate Professor in the Department of Biomedical Engineering at the University of Cincinnati. Before joining the faculty at University of Cincinnati in 2024\, she was an Associate Professor at Mississippi State University (2013 – 2023) and she trained as a postdoctoral research associate at Rice University in the Department of Bioengineering. Dr. Hendrix received all her educational training at Clemson University with a B.S. in Biochemistry\, M.S.\, and Ph.D. In Bioengineering. Dr. Hendrix’s research interests include vascular calcification\, smooth muscle cells\, cell and gene therapy\, and mechanotransduction. Her work has been funded by the National Science Foundation (NSF)\, the National Institutes of Health (NIH)\, and the United States Department of Agriculture (USDA).\n\nIn addition to her passion for vascular research\, Dr. Hendrix is a student advocate and a champion for diversity and inclusion. She has worked to create inclusive spaces for trainee development and success. She has received numerous awards for her efforts including Teacher of the Year\, College of Agriculture and Life Sciences at Mississippi State University\, 2018\; Academy of Distinguished Teachers\, Bagley College of Engineering at Mississippi State University\, 2019\; and Excellence in Diversity and Inclusion Award\, Mississippi Institute of Higher Learning\, 2020. Her pride and joy are the diversity of her research lab and the outstanding accomplishments of her trainees. Dr. Hendrix is the founder of BlackWomenInBME and has hosted sessions for her group at the Biomedical Engineering Society (BMES) Annual meeting since 2018. She is the recipient of the 2021 Biomedical Engineering Society Diversity Award Lecture and the 2025 Mentor Award from the American Association for the Advancement of Science (AAAS). UID:145355-21897164@events.umich.edu URL:https://events.umich.edu/event/145355 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260212T194436 DTSTART;TZID=America/Detroit:20260306T080000 DTEND;TZID=America/Detroit:20260306T170000 SUMMARY:Conference / Symposium:10th Annual RNA Symposium DESCRIPTION:The Center for RNA Biomedicine at the University of Michigan proudly invites you to the 2026 RNA Symposium\, convening thought leaders and pioneering researchers in the field of RNA science and biomedicine.\n\nFriday\, March 6\, 2026\nSaturday\, March 7\, 2026\n\nRNA Frontiers: From Mechanisms to Medicine\n\nThis year’s symposium explores the dynamic world of RNA\, highlighting how fundamental mechanisms and molecular machines are shaping both our understanding of cellular processes and the development of next-generation medical innovations. Through cutting-edge scientific talks and a patient advocacy panel discussion\, we will explore a wide range of topics spanning epigenetics\, genome editing\, RNA structure\, and translational research\, and discover together how RNA is propelling biological discovery from molecular intricacy to real-world impact in medicine and beyond.\n\nScheduled Speakers:\n\nShelley Berger\, Ph.D.\nUniversity of Pennsylvania\n\nKarla Neugebauer\, Ph.D.\nYale School of Medicine\n\nMadeleine Oudin\, Ph.D.\nTufts University\n\nErik Sontheimer\, Ph.D.\nUMass Chan Medical School\n\nNils Walter\, Ph.D.\nUniversity of Michigan\n\nSarah Woodson\, Ph.D.\nJohns Hopkins University\n\nOnline registration ends Friday\, February 20! SPACE IS LIMITED - Register Today! \n\n➡️ Open call for U-M student volunteers who will receive complimentary registration. Email Center Manager Paul Avedisian at paulave@umich.edu for more details! UID:136482-21878770@events.umich.edu URL:https://events.umich.edu/event/136482 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Taubman Biomedical Science Research Building - Kahn Auditorium CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260212T194436 DTSTART;TZID=America/Detroit:20260307T080000 DTEND;TZID=America/Detroit:20260307T170000 SUMMARY:Conference / Symposium:10th Annual RNA Symposium DESCRIPTION:The Center for RNA Biomedicine at the University of Michigan proudly invites you to the 2026 RNA Symposium\, convening thought leaders and pioneering researchers in the field of RNA science and biomedicine.\n\nFriday\, March 6\, 2026\nSaturday\, March 7\, 2026\n\nRNA Frontiers: From Mechanisms to Medicine\n\nThis year’s symposium explores the dynamic world of RNA\, highlighting how fundamental mechanisms and molecular machines are shaping both our understanding of cellular processes and the development of next-generation medical innovations. Through cutting-edge scientific talks and a patient advocacy panel discussion\, we will explore a wide range of topics spanning epigenetics\, genome editing\, RNA structure\, and translational research\, and discover together how RNA is propelling biological discovery from molecular intricacy to real-world impact in medicine and beyond.\n\nScheduled Speakers:\n\nShelley Berger\, Ph.D.\nUniversity of Pennsylvania\n\nKarla Neugebauer\, Ph.D.\nYale School of Medicine\n\nMadeleine Oudin\, Ph.D.\nTufts University\n\nErik Sontheimer\, Ph.D.\nUMass Chan Medical School\n\nNils Walter\, Ph.D.\nUniversity of Michigan\n\nSarah Woodson\, Ph.D.\nJohns Hopkins University\n\nOnline registration ends Friday\, February 20! SPACE IS LIMITED - Register Today! \n\n➡️ Open call for U-M student volunteers who will receive complimentary registration. Email Center Manager Paul Avedisian at paulave@umich.edu for more details! UID:136482-21878771@events.umich.edu URL:https://events.umich.edu/event/136482 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Taubman Biomedical Science Research Building - Kahn Auditorium CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260226T120039 DTSTART;TZID=America/Detroit:20260310T160000 DTEND;TZID=America/Detroit:20260310T170000 SUMMARY:Lecture / Discussion:CPOD Winter/Spring 2026 Seminar Series: “Synthetic heart models for the study of cardiac development and disease” DESCRIPTION:Aitor Aguirre\, Ph.D.\nAssociate Professor\nBiomedical Engineering\nMichigan State University UID:145981-21898222@events.umich.edu URL:https://events.umich.edu/event/145981 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260219T101007 DTSTART;TZID=America/Detroit:20260312T150000 DTEND;TZID=America/Detroit:20260312T160000 SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series DESCRIPTION:Engineering immunotherapies for autoimmunity and cancer\n\nAbstract:\nEffective delivery of drugs to direct immune responses requires an understanding of biological barriers\, physicochemical properties of drug molecules\, formulation and transport in vivo. Designing molecular structures that persist at the administration site or that promote drainage to regional lymphatic networks may enhance immune responses while sparing immune-related adverse events. Here\, drug transport and local elimination mechanisms will be overviewed. Then\, examples of molecular designs to direct drug delivery will be presented. Autoimmune therapies were designed by our lab to promote the drainage of autoantigens to secondary lymphoid organs to treat autoimmune diseases. Specifically\, the size and solubility of these molecular constructs were tuned to promote access to the lymphatic compartment and induce immune tolerance in mouse models of type 1 diabetes. Our lab has also recently explored the design of immunostimulants that persist in tumor tissue after intratumoral/perilesional injection. Intratumoral immunotherapy is proposed to work synergistically with checkpoint inhibitors making a nonresponsive ‘cold’ tumor ‘hot’ by recruiting and activating tumor infiltrating lymphocytes. This approach can suffer from systemic immune-related adverse reactions\, however\, if enough immunostimulant escapes the site of administration. Data on the use of electrostatic mechanisms to promote tumor retention will be presented. These examples underscore the need for rational design of drug molecules or formulations based upon the route of delivery and biological barriers encountered. \n\nBio:\nCory Berkland is the Mark and Becky Levin Professor in the Departments of Biomedical Engineering and Chemistry at Washington University in Saint Louis. Previously\, he was the Solon E. Summerfield Professor in the Department of Pharmaceutical Chemistry and in the Department of Chemical Engineering at The University of Kansas. He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering from Iowa State University in Ames. His lab studies pharmaceuticals and materials with an emphasis on molecular design and transport in the human body. He is a co-founder of Orbis Biosciences (acquired by Adare Pharmaceuticals)\, Savara Pharmaceuticals (NASDAQ:SVRA)\, Bond Biosciences\, Kinimmune\, Axioforce\, and other start-ups. He has served as a board member\, executive\, and fundraiser for these companies. UID:145728-21897738@events.umich.edu URL:https://events.umich.edu/event/145728 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260310T135950 DTSTART;TZID=America/Detroit:20260317T160000 DTEND;TZID=America/Detroit:20260317T180000 SUMMARY:Lecture / Discussion:The Future of Health AI DESCRIPTION:Join industry and startup leaders as they break down how AI is transforming healthcare now and where it’s headed next. Note: This event is for U-M students\, faculty\, and staff.\n\nMarch 17\, 2026\n4PM - 6PM\n​Ross School of Business\n701 Tappan Ave\, Ann Arbor\, MI 48109\, USA\nRobertson Auditorium\n\nRSVP here: https://myumi.ch/y1EmP\n\nEvent Schedule\n\n​4:00 PM\nArrival and Networking\n\n​4:30–6:00 PM\n​Welcome and Introduction\n\n​Perspectives on the Future of Health AI\nJim Mault\, MD\nFounder & Chairman\, BioIntelliSense\n​David Rhew\, MD\nChief Medical Officer\, Microsoft\n\n​Spotlight on U-M Health AI Startups\n\n​Fireside Conversation and Audience Q&A\n\n​6:00–6:30 PM\nNetworking Reception\n\n​This event is hosted by: \n​Pinkert Healthcare Accelerator (Zell Lurie Institute for Entrepreneurship)\n​Michigan Biomedical Venture Fund (Center for Entrepreneurship + Fast Forward Medical Innovation)\n\n​UM Partner Groups:\n​AI & Digital Health Innovation + e-HAIL\n​Michigan Medicine\n​Innovation Partnerships\n​Dept of Computational Medicine & Bioinformatics UID:146126-21898419@events.umich.edu URL:https://events.umich.edu/event/146126 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Ross School of Business - Robertson Auditorium CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260313T155924 DTSTART;TZID=America/Detroit:20260319T150000 DTEND;TZID=America/Detroit:20260319T160000 SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series DESCRIPTION:Patterned Biomaterials: New Tools to Probe and Control Complex Biological Systems\n\nAbstract:\nEngineered materials and molecular sensing tools are transforming how we study and control complex biological systems. Yet many technologies operate at a single scale—either manipulating cellular environments without molecular precision or profiling molecular signals without spatial or mechanical context. My lab addresses this challenge through chemical and materials innovation\, developing scalable platforms that integrate molecular design with quantitative analysis. We focus on two complementary directions: (1) physico-chemical design of soft interfaces with tunable nanoscale architecture and dynamic mechanics to probe and control material–biology interactions\, and (2) biomolecular sensing platforms that combine polymer chemistry\, optical or electrochemical detection\, and data-driven analysis for accessible diagnostics. In this talk\, I will highlight two representative efforts: nature-inspired nanopatterned coatings with dynamically tunable surface topography for long-term antibacterial activity\, and integrated bioanalytical sensing technologies for early\, point-of-care detection of sepsis. \n\nBio:\nDr. Jouha Min is an Assistant Professor in the Department of Chemical Engineering at University of Michigan. She received her B.S. in Chemical Engineering from Cornell University in 2010 and her Ph.D. in Chemical Engineering from MIT\, where she was advised by Paula Hammond and Richard Braatz. She conducted her postdoctoral research with Ralph Weissleder at Harvard Medical School and Massachusetts General Hospital\, where she worked at the interface of engineering\, biology\, and clinical translation. Dr. Min’s research group applies core principles of chemical and biological engineering—including transport phenomena\, reaction kinetics\, materials synthesis\, and systems-level analysis—to develop new methodologies for probing and controlling material–biology interactions across three-dimensional space and time. Her work aims to establish a quantitative and mechanistic foundation for transformative advances in disease diagnosis\, treatment\, and prevention. She is the recipient of several honors\, including the NSF CAREER Award (2025)\, the NIH R35 MIRA Award (2025)\, and the V Foundation V Scholar Award (2023). UID:146152-21898595@events.umich.edu URL:https://events.umich.edu/event/146152 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260212T124527 DTSTART;TZID=America/Detroit:20260323T130000 DTEND;TZID=America/Detroit:20260323T180000 SUMMARY:Conference / Symposium:Institutional Global Health Summit DESCRIPTION:You're invited to the Institutional Global Health Summit\, an afternoon showcasing cutting-edge research\, dynamic debate\, and global perspectives on health for all.\n\nHosted by the Center for Global Health Equity\, this event brings together U-M faculty\, staff\, trainees\, students\, and global health leaders to showcase innovations addressing health for all through the dynamic exchange of ideas between local and international contexts.\n\n📅 Monday\, March 23\, 2026 | 1:00-6:00 PM\n📍 Rackham Amphitheatre\, University of Michigan\n🎟 Registration required (limited to members of the University of Michigan and Michigan Medicine community)\n\nEvent Highlights\n🔬 Research Lightning Talks | 1:15-3:05 PM\nFast-paced presentations from CGHE-supported Impact Scholars\, students\, and faculty across career stages \n \n🤖 Debate: The Role of AI in Global Equity | 3:15-4:15 PM\nFarhana Alarakhiya (Chief Data Innovation Officer\, Aga Khan University) and Bilal Butt\, PhD (Professor\, SEAS\; Senior Advisor\, CGHE) examine whether AI advances or undermines health equity\, moderated by Lou Edje\, MD \n \n🌍 Panel: Global Health in Transition | 4:15-5:00 PM\nMembers of CGHE's External Advisory Board share insights on navigating funding landscapes\, building partnerships\, and career pathways \n \n🎨 Poster Reception | 5:00-6:00 PM\nEngage with fellow researchers\, explore innovative projects\, and network with colleagues \n \nView the full program at https://myumi.ch/y15d4 UID:145260-21896960@events.umich.edu URL:https://events.umich.edu/event/145260 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Rackham Graduate School (Horace H.) - Auditorium CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260323T082306 DTSTART;TZID=America/Detroit:20260324T150000 DTEND;TZID=America/Detroit:20260324T170000 SUMMARY:Workshop / Seminar:MICDE State of AI & the Future of Institutions DESCRIPTION:The State of AI & the Future of Institutions event is hosted by the Michigan Institute for Computational Discovery and Engineering (MICDE). We bring together scholars and institutional leaders to explore the current state and future trajectory of AI\; how it may reshape institutions and how we can be better prepared for its disruptive impact. This event aims to move beyond abstract debate and towards actionable insights and assess how institutions can more actively shape a more resilient and responsible future. We anticipate this event to recur every semester. UID:146034-21898298@events.umich.edu URL:https://events.umich.edu/event/146034 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Palmer Commons - Forum Hall CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260226T120252 DTSTART;TZID=America/Detroit:20260324T160000 DTEND;TZID=America/Detroit:20260324T170000 SUMMARY:Lecture / Discussion:CPOD Winter/Spring 2026 Seminar Series: \"Wnt you thought you knew about Wnt signaling\" DESCRIPTION:Stephanie Grainger\, Ph.D.\nAssistant Professor\nCell Biology\nVan Andel Institute UID:145982-21898223@events.umich.edu URL:https://events.umich.edu/event/145982 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260313T072550 DTSTART;TZID=America/Detroit:20260324T183000 DTEND;TZID=America/Detroit:20260324T193000 SUMMARY:Careers / Jobs:GEICO Corporate Information Sessions DESCRIPTION:3/24/2026 | 6:30 pm | DOW 1018 (FOOD PROVIDED: Cottage Inn Pizza)\nMajors: All Engineering Majors\nPositions: Full Time\, Intern\nDegrees: Bachelors\, Masters\n\nResumes Collected\nUS Citizenship or Permanent Resident\n\nGEICO (Government Employees Insurance Company) is a leading American auto insurer\, ranking as the second-largest in the U.S. A Berkshire Hathaway subsidiary founded in 1936\, it specializes in direct-to-consumer private passenger auto insurance\, offering policies online and by phone. GEICO also covers motorcycles\, RVs\, homeowners\, and renters. UID:146554-21899265@events.umich.edu URL:https://events.umich.edu/event/146554 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Chemistry Dow Lab - 1018 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260220T102635 DTSTART;TZID=America/Detroit:20260326T100000 DTEND;TZID=America/Detroit:20260326T114500 SUMMARY:Workshop / Seminar:SCSAP Special Research Seminar and Town Hall Event DESCRIPTION:SCSAP Special Research Seminar and Town Hall Discussion Event\nDate: Thursday\, March 26\, 2026\nLocation: Live In-Person Only (Will not be streamed or recorded)\n NCRC Building 18\, Dining Hall\nFREE TO ALL\, Everyone is Welcome\, \nLite Refreshments provided\n\nFEATURING: Dr. Aviv Regev\, Executive Vice President and Head of Genentech Research and Early Development and Executive Committee of the Human Cell Atlas\n\n*PLEASE REGISTER FOR THIS EVENT*\n\nTwo Events of Interest: \n\n10:00–10:45 AM- Talk Title: “Towards Unified Cell and Tissue Oracles”- Featuring Dr. Regev- Hosted by SCSAP \n\n11:00–11:45 AM Town Hall Discussion Featuring Dr. Regev and an invited faculty panel – event will cover several topics such as the future of single cell spatial-omics\, strategies for productive collaboration\, AI development of new drugs. UID:145768-21897796@events.umich.edu URL:https://events.umich.edu/event/145768 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:North Campus Research Complex Building 18 - Dining Hall CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260129T164237 DTSTART;TZID=America/Detroit:20260326T120000 DTEND;TZID=America/Detroit:20260326T133000 SUMMARY:Livestream / Virtual:Building Industry Partnerships Webinar Series DESCRIPTION:Federal funding trends\, including from NSF\, DOE and ARPA agencies\, indicate increasing interest in translational research – supporting the pathways for fundamental discoveries to have broader societal\, economic or public impact. New funding programs might require researchers to demonstrate their research impact at the proposal stage through established partnerships with companies that signal market interest or investment\, formal commitments like licensing agreements\, and/or evidence of technology readiness levels. Researchers who build these industry partnerships in advance will have a critical edge in a competitive funding landscape.\n\nThe Office of Research Development will host a webinar series for U-M researchers that explains why and how to build industry partnerships that advance mutual R&D goals. Webinars will take place noon-1:30 pm each day\; calendar invites will be sent upon registration. \n\nFebruary 25: Discovery to Innovation - Gain a practical framework for deciding when to engage industry\, how to demonstrate impact credibly and which funding mechanisms align with research maturing and scholarly goals.\nMarch 26: Industry Engagement for Faculty: From Early Signals to Funded Partnerships - Learn meaningful engagement strategies across the research lifecycle\, emphasizing alignment with academic incentives\, research integrity and appropriate funding mechanisms. \nApril 9: Building Industry Partnerships that Last: Whom to Talk to\, What to Ask - Learn how to identify the right industry counterparts\, structure early conversations to surface meaningful research and translational opportunities and set expectations that can evolve into sustained collaboration. \nContact RD-Support@umich.edu with questions. UID:144802-21895960@events.umich.edu URL:https://events.umich.edu/event/144802 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Off Campus Location CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260317T143000 DTSTART;TZID=America/Detroit:20260326T150000 DTEND;TZID=America/Detroit:20260326T160000 SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series DESCRIPTION:Surgery with sound waves: delivering acoustic energy to the body for ultrasound surgery (histotripsy)\n\nAbstract:\nHistotripsy is a non-invasive\, non-thermal\, and non-ionizing tissue ablation method that was recently (Oct. 2023) approved by the FDA for the non-invasive treatment of liver tumors. Histotripsy is a platform technology\, with the potential to enable truly non-invasive surgery for many applications throughout the body\, from the abdominal region to the limbs\, brain\, and spine. However\, we currently cannot perform histotripsy everywhere in the body due to limitations in our ability to safely deliver sufficient acoustic energy to the target through heterogeneous\, attenuating bodily tissues. In this talk\, I will present my work to (1) numerically model and quantify acoustic energy delivery to the body\, and (2) optimize acoustic energy delivery through complex tissues via adaptive signal processing methods. I will discuss how these technologies will help expand the region where we can perform histotripsy\, broaden the population of patients who can receive histotripsy treatment\, and enable novel histotripsy applications. \n\nBio:\nDr. Ellen Yeats is a Postdoctoral Research Fellow in the Department of Biomedical Engineering and member of the Histotripsy Lab\, where she is advised by Dr. Zhen Xu and Dr. Timothy Hall. She received her B.S.E. in Biomedical Engineering from Vanderbilt University in 2017 and her Ph.D. in Biomedical Engineering from the University of Michigan in 2024. In 2025\, Dr. Yeats was awarded an NIH T32 Training Fellowship through the Michigan Translational Imaging Program (M-TIP) with the Department of Radiology of University of Michigan Medicine\, where she is working with Dr. Shane Wells to develop improved imaging guidance and targeting for histotripsy. Through her research\, Dr. Yeats develops technologies that optimize the targeting and delivery of acoustic energy to the body for histotripsy. Her work aims to improve current clinical histotripsy treatments in the liver and to expand histotripsy applications to new\, challenging targets in the pelvis and spine. UID:146698-21899492@events.umich.edu URL:https://events.umich.edu/event/146698 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260318T082724 DTSTART;TZID=America/Detroit:20260402T150000 DTEND;TZID=America/Detroit:20260402T160000 SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series DESCRIPTION:Convergence of light\, devices\, and molecules to detect and treat cancer\n\nAbstract:\nSurgeons traditionally rely on vision and touch to distinguish cancerous from healthy tissue\, which risks incomplete tumor removal. To enhance precision\, we developed Cancer Viewing Glasses (CVGs) that provide real-time intraoperative visualization of tumors and sentinel lymph nodes without disrupting the surgical workflow. CVGs detect near-infrared fluorescence (NIRF) from tumor-targeted molecular probes and project both NIRF and visible light to a head-mounted display\, enabling direct access to the surgical field under normal lighting conditions. In both mouse models and cancer patients\, CVGs enabled real-time image guidance for complete tumor resection\, with ongoing clinical studies demonstrating improved surgical throughput and accuracy. \n\nBio:\nDr. Samuel Achilefu is the inaugural Chair and Professor of the Biomedical Engineering Department at the University of Texas Southwestern Medical Center in Dallas\, Texas\, USA. He also holds the Lyda Hill Distinguished University Chair and is a Professor of Radiology and the Simons Cancer Center. He is an international leader in optical and multimodal imaging\, image-guided cancer surgery\, portable imaging devices\, and nanotechnology. His innovative research and more than 70 U.S. patents have significantly contributed to laboratory and clinical medicine. Dr. Achilefu is a member of the National Academies of Engineering and Medicine. He is also a fellow of the National Academy of Inventors\, AAAS\, AIMBE\, and many other professional societies. He has received over 20 national and international awards\, including the Briton Chance Award. UID:146729-21899558@events.umich.edu URL:https://events.umich.edu/event/146729 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260408T094420 DTSTART;TZID=America/Detroit:20260408T160000 DTEND;TZID=America/Detroit:20260408T170000 SUMMARY:Workshop / Seminar:CCMB/DCMB Weekly Seminar Series featuring Ting Wang\, PhD (Professor of Medicine and Head\, Department of Genetics WashU Medicine) DESCRIPTION:CCMB/DCMB Seminar by Ting Wang\, PhD\n\n\"Unmasked: transposable elements as drivers and targets in cancer\"\n\nAbstract\n\nTransposable elements (TEs) represent almost half of the human genome. Historically deemed ‘junk DNA’\, recent technological advancements have stimulated a wave of research into the functional impact of TEs on gene-regulatory networks in evolution and development\, as well as in diseases including cancer. The genetic and epigenetic evolution of cancer involves the exploitation of TEs\, whereby TEs contribute directly to cancer-specific gene activities. I will provide a perspective on the role of TEs in cancer as being a ‘double-edged sword’\, both promoting cancer evolution and representing a vulnerability that could be exploited in cancer therapy. \n\nThe CCMB Seminar Series (Sponsored by DCMB) is held at Medical Science Building 1 (MS1)\, Room 4B700\, each Wednesday\, at 4:00 pm EST\, on bioinformatics-related topics.Each seminar is presented by an invited guest speaker. These seminars are live-streamed on Zoom. UID:143699-21893661@events.umich.edu URL:https://events.umich.edu/event/143699 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Medical Science Unit I - 5330 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260129T164237 DTSTART;TZID=America/Detroit:20260409T120000 DTEND;TZID=America/Detroit:20260409T133000 SUMMARY:Livestream / Virtual:Building Industry Partnerships Webinar Series DESCRIPTION:Federal funding trends\, including from NSF\, DOE and ARPA agencies\, indicate increasing interest in translational research – supporting the pathways for fundamental discoveries to have broader societal\, economic or public impact. New funding programs might require researchers to demonstrate their research impact at the proposal stage through established partnerships with companies that signal market interest or investment\, formal commitments like licensing agreements\, and/or evidence of technology readiness levels. Researchers who build these industry partnerships in advance will have a critical edge in a competitive funding landscape.\n\nThe Office of Research Development will host a webinar series for U-M researchers that explains why and how to build industry partnerships that advance mutual R&D goals. Webinars will take place noon-1:30 pm each day\; calendar invites will be sent upon registration. \n\nFebruary 25: Discovery to Innovation - Gain a practical framework for deciding when to engage industry\, how to demonstrate impact credibly and which funding mechanisms align with research maturing and scholarly goals.\nMarch 26: Industry Engagement for Faculty: From Early Signals to Funded Partnerships - Learn meaningful engagement strategies across the research lifecycle\, emphasizing alignment with academic incentives\, research integrity and appropriate funding mechanisms. \nApril 9: Building Industry Partnerships that Last: Whom to Talk to\, What to Ask - Learn how to identify the right industry counterparts\, structure early conversations to surface meaningful research and translational opportunities and set expectations that can evolve into sustained collaboration. \nContact RD-Support@umich.edu with questions. UID:144802-21895961@events.umich.edu URL:https://events.umich.edu/event/144802 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Off Campus Location CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260318T101203 DTSTART;TZID=America/Detroit:20260409T150000 DTEND;TZID=America/Detroit:20260409T160000 SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series DESCRIPTION:Bioengineering Human Embryo and Organ Models\n\nAbstract:\nEarly human development remains largely mysterious and challenging to study. In this talk\, I will describe our efforts to harness human pluripotent stem cells (hPSCs) and bioengineering approaches to create controllable models of human peri-gastrulation development and early organogenesis. These models recapitulate key in vivo developmental landmarks\, including amniotic cavity formation\, amniotic ectoderm-epiblast patterning\, primordial germ cell specification\, embryonic germ layer organization\, yolk sac formation\, and primitive hematopoiesis. Our current work focuses on using these controllable models as experimental platforms to dissect the molecular and genetic mechanisms underlying cell fate decisions\, tissue patterning\, and self-organization during human peri-gastrulation.\n\nI will also discuss our application of bioengineering tools and hPSCs to model critical aspects of early human neural development\, including neural patterning in both brain and spinal cord regions\, along rostrocaudal and dorsoventral axes. Ongoing projects further aim to model key features of human heart and gut tube development\, as well as somitogenesis. Together\, these efforts have established a suite of bioengineered human embryo and organ models with in vivo-like spatiotemporal cell differentiation and organization\, providing powerful platforms for studying human development\, physiology\, and disease.\n\nBio:\nDr. Jianping Fu is a Professor of Mechanical Engineering at the University of Michigan whose research bridges bioengineering\, stem cell biology\, and developmental biology to advance understanding of human development and disease. He is internationally recognized for pioneering work in “Artificial Embryos\,” named one of MIT Technology Review’s 10 Breakthrough Technologies of 2018 and “the Method of 2023” by Nature Methods. Dr. Fu has received major awards from the National Science Foundation\, the American Chemical Society\, the Alexander von Humboldt Foundation\, and the Biomedical Engineering Society (BMES). He is an elected Fellow of AAAS\, AIMBE\, RSC\, ASME\, IAMBE\, and BMES\, and serves on the Governing Council of IAMBE. In addition to his research\, Dr. Fu has been deeply engaged in scientific leadership and service. He served on the ISSCR Guidelines Working Group and now chairs the ISSCR Scientific Programs Committee. In recognition of his service\, he received the ISSCR Public Service Award in 2025. He is currently Editor-in-Chief of npj Regenerative Medicine and serves on editorial boards of several journals including Cell Stem Cell and Biophysical Journal. UID:146731-21899566@events.umich.edu URL:https://events.umich.edu/event/146731 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260226T120509 DTSTART;TZID=America/Detroit:20260414T160000 DTEND;TZID=America/Detroit:20260414T170000 SUMMARY:Lecture / Discussion:CPOD Winter/Spring 2026 Seminar Series: \"How life finds a way: resilience in mammalian embryogenesis\" DESCRIPTION:Sarah Bowling\, Ph.D.\nAssistant Professor\nDevelopmental Biology\nStanford University UID:145983-21898224@events.umich.edu URL:https://events.umich.edu/event/145983 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Taubman Biomedical Science Research Building - ABC Seminar Rooms CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260415T165612 DTSTART;TZID=America/Detroit:20260415T150000 DTEND;TZID=America/Detroit:20260415T160000 SUMMARY:Workshop / Seminar:CCMB Tuesday Popup: Biomedical Gen AI Learning Community DESCRIPTION:AI tools for research are advancing at a pace that often outstrips traditional academic training. These tools are powerful\, but using them effectively to produce high quality research is a skill in itself. So how do we use AI to move faster and accelerate biological discovery without sacrificing scientific rigor and our sense of engagement with our work?\n\nWe hope to build a community dedicated to keeping up with new tools\, sharing ai-augmented research workflows what work well\, and staying human in an AI world. \n\nWe are launching the Biomedical Gen AI Learning Community!\n\nOpen to: Anyone in the UM bioinformatics and biomedical community - researchers\, students\, and staff. \n\nHow The Learning Community Works:\nOur biweekly 60-minute sessions are broken into three high-impact segments:\n\nThe Spotlight (20 mins): A volunteer demonstrates a specific workflow they’ve integrated into their research. (Examples: Hypothesis generation\, AI agent creation\, GitHub management\, or Literature synthesis).\n\nFoundational Knowledge (20 mins): A focused tutorial on the skills needed to direct AI tools and critically evaluate outputs. (Example: Key safety considerations when deploying agents or best practices for software management).\n\nThe Human Side (10 mins): An open\, facilitated discussion on navigating our changing relationship with work\, learning\, and intellectual identity in the age of AI. (Example: The Engagement Gap: Talking about the 'boredom' of automation—how to stay excited about a project when the AI is doing the heavy lifting?)\n\nOur First Session\nTopic: Literature Research: Search to Synthesis\nWhen: April 21st | 3:00 - 4:00 pm\nWhere: Medical Science Building 1 (MS1)\, Room 4B700\n\nWe’ll be walking through a workflow for literature search and synthesis using tools like Claude\, NotebookLM and SciSpace to synthesize high-quality reports without losing the \"gold\" in the data.\n\nThe Biomedical Gen AI Learning Community is sponsored by the Center for Computational Medicine and Bioinformatics (DCMB) UID:147782-21901965@events.umich.edu URL:https://events.umich.edu/event/147782 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Medical Science Unit I - 4B700 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260408T101448 DTSTART;TZID=America/Detroit:20260416T150000 DTEND;TZID=America/Detroit:20260416T160000 SUMMARY:Workshop / Seminar:Biomedical Engineering (BME 500) Seminar Series DESCRIPTION:Tissue-Inspired Synthetic Biomaterials and Applications in Cancer\nAbstract:\nMost environments available to study how human cells behave are two-dimensional (2D). In real tissue\, cells live surrounded by a three-dimensional (3D) extracellular matrix (ECM)\, which provides structure\, drives cell function\, and is dynamically remodeled by the cells within. A major limitation of the few examples of 3D cell culture environments that do exist (typically made from assemblages of proteins) is that their constituents are undefined\, and they have unacceptable batch-to-batch variability. On the other end of the spectrum\, the major drawbacks to using engineered\, synthetic environments is their over-simplicity and lack of resemblance to real tissue. My lab’s unique approach to biomaterial design is that we create cheap and easy-to-use\, yet complex representations of the ECM of specific tissues. My lab’s tissue-customized environments are hydrogels from synthetic polymers that replicate a tissue’s 3D geometry\, the stiffness of that tissue\, and all the integrin-binding and protease-degradable components of the ECM of the tissue of interest. We made biomaterial designs for brain\, bone marrow\, omentum\, and lung\, and we have applied our approach to several complex problems in biology (e.g.\, astrocyte reactivity\, mesenchymal stem cell differentiation\, ovarian cancer\, etc.). \n\nIn this seminar\, I’ll discuss how we use our engineering principles to create these environments and show how we’ve begun to use them to study grand challenges in cancer biology. One of the overwhelming challenges in treating metastatic cancer is that tumors in the brain\, lung\, skeleton\, and liver are typically drug resistant\, and we do not have a good understanding of why these tumors evade therapy. The biomaterials we have built over the years are well suited for drug screening applications and to study how the extracellular microenvironment regulates the metastatic spread of cancer. \nBio:\nShelly Peyton is Professor and Department Chair of Biomedical Engineering at Tufts University. She received her B.S. in Chemical Engineering from Northwestern University in 2002 and went on to obtain her MS and PhD in Chemical Engineering from the University of California\, Irvine in 2007. She was then an NIH Kirschstein post-doctoral fellow in the Biological Engineering department at MIT before starting her academic appointment in Chemical Engineering at the University of Massachusetts Amherst in 2011. At UMass she was named the Barry and Afsaneh Siadat Professional Development Professor\, Armstrong Professor\, Conti Fellow\, and Provost Professor before moving to Tufts University to become chair of Biomedical Engineering in 2024. At Tufts\, the Peyton lab is an interdisciplinary group of engineers and biologists that create bioinspired and dynamic models of human tissue with both synthetic biomaterials and decellularized tissues. They use these tissue models to 1) understand the physical relationship between metastatic cancer cells and the tissues to which they spread\, 2) uncover the role of the extracellular matrix and its dynamics in drug resistant cancers\, and 3) quantify how forces from traumatic brain injury damage cells within the brain. Shelly’s honors include a Pew Biomedical Scholarship\, an NIH New Innovator Award\, an NSF CAREER award\, Biomedical Engineering Society fellow\, and an American Institute for Medical and Biological Engineering fellow. Outside of her research and her Chair’s role\, Shelly is passionate about graduate student training and diversifying the academy. She was awarded an Outstanding Teaching Award and a Diversity Award from the College of Engineering at UMass\, has led an REU Site\, co-directed a Biotechnology (BTP) NIH T32 training program\, and was lead PI of a PREP program at UMass. Since 2013\, the Peyton has continuously run an NSF- and privately funded program called Engineering the Cell\, which pays high school students with no prior research experience to work in the Peyton lab for 5 weeks every summer. Outside of her work\, Shelly is an avid cyclist\, enjoys board games\, lego\, travel\, and coaches ultimate frisbee. UID:147525-21901179@events.umich.edu URL:https://events.umich.edu/event/147525 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:biomedical engineering LOCATION:Lurie Biomedical Engineering (formerly ATL) - 1130 CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260409T105118 DTSTART;TZID=America/Detroit:20260420T130000 DTEND;TZID=America/Detroit:20260420T140000 SUMMARY:Workshop / Seminar:Single Cell Spatial Analysis Monthly Seminar Series DESCRIPTION:TITLE: Simultaneous CRISPR screening and spatial transcriptomics reveals intracellular and intercellular transcriptional circuits.\n\nFEATURING: \nSamouil L. Farhi\, Ph.D. Director of the Spatial Technology Platform at the Broad Institute of MIT and Harvard\n\nFor more details Visit: https://singlecellspatialanalysis.umich.edu/monthlyseminarseries/\nZoom Info: \nMeeting ID: 998 7259 4985\nPasscode: 786053\n\nABSTRACT: \nPerturb-FISH combines spatial transcriptomics with optical detection of in situ amplified guide RNAs. Perturb-FISH recovers intracellular effects that are consistent with Perturb-seq results in cultured monocytes\, and finds density-dependent regulation of the innate immune response. Pairing Perturb-FISH with a functional readout in a screen of autism spectrum disorder risk genes\, shows common calcium activity phenotypes in induced pluripotent stem cell derived astrocytes and their associated molecular pathways. Finally\, Perturb-FISH can identify neighborhood dependent perturbation effects in a complex tissue by showing immune-tumor interactions in a xenograft model engrafted with human PBMCs. Perturb-FISH is thus a general method for studying the genetic and molecular associations of spatial and functional biology at single-cell resolution. UID:147561-21901279@events.umich.edu URL:https://events.umich.edu/event/147561 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:North Campus Research Complex Building 10 - Research Auditorium CONTACT: END:VEVENT BEGIN:VEVENT DTSTAMP:20260414T071856 DTSTART;TZID=America/Detroit:20260423T130000 DTEND;TZID=America/Detroit:20260423T180000 SUMMARY:Conference / Symposium:2026 Michigan Pioneer Fellows Symposium DESCRIPTION:Please join us for the upcoming Annual Michigan Pioneer Fellows Symposium\, when we will celebrate the invaluable research contributions of postdoctoral fellows and highlight the innovative work being done by Pioneer Fellows and other postdoctoral researchers across the University of Michigan. \n\nRegistration is open through April 20! \nPoster abstract submission is now closed.\n\n2026 Michigan Pioneer Fellows Symposium:\n1:00–6:00 p.m.\, April 23\, 2026\nBSRB Kahn Auditorium\n\nSchedule:\n1:00 Welcome and introductions\n1:05 Talks by Pioneer Fellows\n3:30 Keynote address: “New Approach Methodologies (NAMs) to Accelerate Clinical Trials in a Dish (CTiD)\,” Joseph C. Wu\, M.D.\, Ph.D. Professor & Director\, Stanford Cardiovascular Institute\, Stanford University\n4:30 Poster session\n5:30 Concluding remarks and reception\n\nAbstract:\nDrug discovery and development continue to face significant challenges\, with over 90% of candidate drugs failing in clinical trials. These efficacy failures are primarily due to inherent species-specific differences\, fundamental biological variances between model organisms and humans\, and the limitations of existing models to accurately reflect the complexity of human disease and treatment responses. In this discussion\, I will explore how the NIH and FDA are advocating for new alternative methodologies (NAMs) to reduce or replace animal testing. I will highlight recent advancements in technologies such as stem cells\, organoids\, and microphysiological systems (MPS)\, along with the roles of clinical genomics and AI/ML. Additionally\, I will examine how these platforms can collaboratively enhance our understanding of rare orphan diseases\, facilitate drug discovery\, support precision medicine\, and enable clinical trials in a dish (CTiD).\n\nAbout the Speaker:\nJoseph C. Wu\, MD\, PhD is Director of Stanford Cardiovascular Institute and Simon H. Stertzer\, MD\, Professor of Medicine and Radiology at Stanford University. Dr. Wu received his MD from Yale University and PhD (Molecular & Medical Pharmacology) at University of California\, Los Angeles. He is board certified in cardiovascular medicine. His lab works on genomics\, stem cells/organoids\, AI/ML\, and drug discovery. The main goals are to (i) understand basic disease mechanisms\, (ii) implement precision medicine for patients\, and (iii) accelerate drug discovery via “new alternative methodologies” (NAMs) and “clinical trial in a dish” (CTiD) concept. Dr. Wu has published >700 manuscripts with H-index of 147 on Google scholar. He is listed as top 0.1% of highly cited researchers by Web of Science for past 7 years (2018-2024). Dr. Wu has received several awards\, including the NIH Director’s New Innovator Award\, NIH Roadmap Transformative Award\, Presidential Early Career Award for Scientists and Engineers (PECASE) given out by President Obama at the White House\, American Heart Association (AHA) Distinguished Scientist Award\, AHA Merit Award\, and Burroughs Wellcome Foundation Innovation in Regulatory Science Award. Dr. Wu serves on the FDA Cellular\, Tissue\, and Gene Therapies Advisory Committee. He is on the Board of the Keystone Symposia and American Heart Association. He is a past President of the American Heart Association (2023-2024). Dr. Wu is an elected member or fellow of the American Society for Clinical Investigation (ASCI)\, Association of University Cardiologists (AUC)\, American Institute for Medical and Biological Engineering (AIMBE)\, American Association of Physicians (AAP)\, Academia Sinica (Taiwan)\, American Association for the Advancement of Science (AAAS)\, Asian American Academy of Science and Engineering (AAASE)\, National Academy of Inventors (NAI)\, and National Academy of Medicine (NAM). UID:145980-21898221@events.umich.edu URL:https://events.umich.edu/event/145980 CLASS:PUBLIC STATUS:CONFIRMED CATEGORIES:Biomedical Engineering LOCATION:Taubman Biomedical Science Research Building - Kahn Auditorium CONTACT: END:VEVENT END:VCALENDAR